Refine
Has Fulltext
- yes (266)
Year of publication
Document Type
- Journal article (156)
- Doctoral Thesis (96)
- Complete part of issue (10)
- Conference Proceeding (3)
- Preprint (1)
Language
- English (148)
- German (115)
- Multiple languages (3)
Keywords
- multiple sclerosis (11)
- Endothel (9)
- Multiple Sklerose (9)
- EAE (8)
- B cells (7)
- Habichtskraut (7)
- Geobotanik (6)
- MS (6)
- Pemphigus (6)
- Pflanzengeographie (6)
- SGLT1 (6)
- expression (6)
- inflammation (6)
- Angiogenese (5)
- Glutamattransporter (5)
- Ratte (5)
- Bavaria (4)
- Biologie (4)
- Blut-Hirn-Schranke (4)
- CEACAM1 (4)
- ELISPOT (4)
- Geobotanik ; Pflanzengeographie (4)
- Kation (4)
- NPY (4)
- OCT (4)
- RS1 (4)
- Stammzelle (4)
- Zelladhäsion (4)
- cell adhesion (4)
- distribution (4)
- endothelium (4)
- experimental autoimmune encephalomyelitis (4)
- induced pluripotent stem cells (4)
- microglia (4)
- mouse (4)
- oligodendrocytes (4)
- 5-HT1A (3)
- 5-HT2C (3)
- Adventitia (3)
- Asteraceae (3)
- Bayern (3)
- Brombeere (3)
- CNS (3)
- Cadherine (3)
- Desmosom (3)
- Germany (3)
- Glukose (3)
- Hieracium (3)
- Immunhistochemie (3)
- Keratinozyten (3)
- Kerntransport (3)
- Korbblütler (3)
- NLS (3)
- Niere (3)
- Ranunculus auricomus (3)
- Regulation (3)
- Rubus (3)
- Schleswig-Holstein (3)
- Tumor (3)
- VE-Cadherin (3)
- blood vessel (3)
- brain (3)
- cardiomyocytes (3)
- glucose (3)
- glutamate transporters (3)
- inhibition (3)
- ischemia (3)
- mRNA (3)
- macrophages (3)
- mice (3)
- neurodegeneration (3)
- new species (3)
- pemphigus (3)
- rOCT1 (3)
- rat (3)
- regulation (3)
- relapse (3)
- 18F-FDG (2)
- Aktin (2)
- Autoimmunität (2)
- B-Zelle (2)
- Brain-derived neurotrophic factor (2)
- Brustkrebs (2)
- Cadherin (2)
- Carrier-Proteine (2)
- Coexpression (2)
- Desmoglein (2)
- Desmogleine (2)
- Durchflusscytometrie (2)
- EAAC1 (2)
- Elektronenmikroskopie (2)
- Endothelbarriere (2)
- Entzündung (2)
- Evolution (2)
- Experimentelle autoimmune Enzephalomyelitis (2)
- FGFR1 (2)
- FTY720 (2)
- Ficaria calthifolia (2)
- Ficaria verna (2)
- Fingolimod (2)
- Franconia (2)
- Franken (2)
- GLAST (2)
- GLT1 (2)
- GLUT2 (2)
- Glucose (2)
- Glucosetransportproteine (2)
- Herz (2)
- Immuncytochemie (2)
- Inhibition (2)
- Kanadaptin (2)
- Karyotyp (2)
- Kationentransporter (2)
- Maus (2)
- Multiple sclerosis (2)
- Mutationsanalyse (2)
- Myokarditis (2)
- Occludin (2)
- Organic cation transporter (2)
- Organische Kationentransporter (2)
- PET (2)
- Pflanzen (2)
- Progerie (2)
- Retina (2)
- Scherstress (2)
- Stofftransport <Biologie> (2)
- Stressfasern (2)
- Stroma (2)
- Systematik (2)
- TGFβ signaling (2)
- Trifolium micranthum (2)
- Unterfranken (2)
- Vegetation (2)
- Vorkommen (2)
- Vorläuferzelle (2)
- Zellkern (2)
- actin (2)
- adherens junction (2)
- aging (2)
- amygdala (2)
- anatomy (2)
- angiogenesis (2)
- animal models (2)
- bariatric surgery (2)
- biomedical applications (2)
- blood brain barrier (2)
- calcium (2)
- cell culture (2)
- central nervous system (2)
- cerebellum (2)
- desmosome (2)
- diabetes (2)
- diabetic nephropathy (2)
- diabetic retinopathy (2)
- differential expression (2)
- electron microscopy (2)
- emphysema (2)
- extracellular matrix (2)
- fatty acid (2)
- glucocorticoid receptor (2)
- heart (2)
- hiPSC-CM (2)
- human induced pluripotent stem cells (2)
- immunohistochemistry (2)
- in situ hybridization (2)
- in vitro (2)
- kidney (2)
- lectotype (2)
- lesions (2)
- medical research (2)
- mitochondria (2)
- mucoepidermoid carcinoma (2)
- myocarditis (2)
- neural (2)
- neuroinflammation (2)
- neuroprotection (2)
- neurotrophins (2)
- new subspecies (2)
- nucleus (2)
- olfactory epithelium (2)
- olfaktorisches Epithel (2)
- organoid (2)
- organoids (2)
- oxidative stress (2)
- parotid gland (2)
- peroxisomes (2)
- photon-counting (2)
- pleomorphic adenoma (2)
- positron emission tomography (2)
- predictive value (2)
- progeria (2)
- regeneration (2)
- remyelination (2)
- retina (2)
- retinitis pigmentosa (2)
- secretion (2)
- serotonergic system (2)
- shear stress (2)
- stem cell therapy (2)
- stroke (2)
- stroma (2)
- tracer (2)
- transgenic mice (2)
- triple in situ hybridization (2)
- ultrastructure (2)
- vasculogenesis (2)
- vegetation (2)
- --- (1)
- 2C-values (1)
- A549 cell line (1)
- ADHD (1)
- AMD (1)
- ARF (1)
- ATF6 (1)
- AZD4547 (1)
- Acetylcholin (1)
- Actin (1)
- Aderhaut (1)
- Adherens-Junction (1)
- Adhärens-/ Occludensjunktionen (1)
- Adhärenskontakte (1)
- Adipositas (1)
- Agamospermy (1)
- Akt (1)
- Alemtuzumab (1)
- Alzheimers disease (1)
- Aminosäuren (1)
- Amrum (1)
- Amygdala (1)
- Amyotrophic-lateral-sclerosis (1)
- Angst (1)
- Anti-CD52-Antikörper (1)
- Antigen CD44 (1)
- Anxiety (1)
- Aortenringassay (1)
- Apomixis (1)
- Armplexusverletzung (1)
- Art (1)
- Arteriosklerose (1)
- Aryl Hydrocarbon Hydroxylase (1)
- Asymmetrie (1)
- Atemwege (1)
- Atherosklerose (1)
- Atlantischer Wildkohl (1)
- Atlas (1)
- Autoantikörper (1)
- Autoimmundermatose (1)
- Autoimmunerkrankung (1)
- Autoimmunity (1)
- Axis (1)
- Axon degeneration (1)
- Axon growth (1)
- Axonal transport (1)
- B-Lymphozyt (1)
- B-Zell-Aggregat (1)
- B-Zellen (1)
- BDNF (1)
- BRP (1)
- BSTA (1)
- Basal Ganglia (1)
- Basalganglien (1)
- Basiocciput (1)
- Basiokziput (1)
- Baumart (1)
- Bayerische Alpen (1)
- Bayern (Nord) (1)
- Benzo(a)pyrene (1)
- Berlin (1)
- Bindestelle (1)
- Biodiversität (1)
- Biomechanical properties (1)
- Biomechanische Eigenschaften (1)
- Bioprozessmethode (1)
- Boden (1)
- Bombesin ; Bombesin receptor ; Chromosomal localization (1)
- Botanische Nomenklatur (1)
- Brain (1)
- Brassica oleracea (1)
- Brillantgrün (1)
- Brombeerart (1)
- Bruchpilot (1)
- CD4 T cells (1)
- CD44 (1)
- CD52 (1)
- CDC42 (1)
- CMV (1)
- CNTF (1)
- COPD (1)
- COS cell expression (1)
- CPFE (1)
- CRISPR/Cas-Methode (1)
- CXCL12-abundant reticular (CAR)-cells (1)
- Calcium (1)
- Cancellous bone (1)
- Cancer models (1)
- Cancer therapeutic resistance (1)
- Carcinogen (1)
- Cardiac Angiogenesis Assay (1)
- Caryophyllaceae (1)
- Cas9 (1)
- Cationentransporter (1)
- Cell reprogramming (1)
- Cell therapy (1)
- Cell-cell communication (1)
- Cells (1)
- Cerastium brachypetalum (1)
- Cerastium tenoreanum (1)
- ChAT (1)
- ChT1 (1)
- Chamaesyce (1)
- Charakterisierung (1)
- Chimären (1)
- Chinin (1)
- Chirurgie (1)
- Choroidea (1)
- Ciliary neurotrophic factor (1)
- Coiled coil (1)
- Coiled-Coile (1)
- Cone-beam computed tomography (1)
- Connexin (1)
- Copaxone® (1)
- Corpus amygdaloideum (1)
- Cortico-striatal projection neurons (1)
- Corticosteroide (1)
- CreERT2 (1)
- Cx3cr1 (1)
- Cyclo-AMP (1)
- Cycloheximide (1)
- Cytokeratin (1)
- Cytologie (1)
- Cytomatrix der aktiven Zone (1)
- Cytoskeleton (1)
- DAMGO (1)
- DNA (1)
- DNA methylation (1)
- DNA weight (1)
- DNA-Binding (1)
- DSG2 (1)
- Darmresorption (1)
- Darmwandnervensystem (1)
- Dens axis (1)
- Developmental biology (1)
- Dexamethason (1)
- Dieldrin (1)
- Drosophilia (1)
- Dsg3-Depletion (1)
- Dsg3-depletion (1)
- Dünndarm (1)
- EBV (1)
- ECM (1)
- ECV304 (1)
- EEOS (1)
- ER stress (1)
- ER-Stress (1)
- ERK (1)
- Echinina (1)
- Elbow (1)
- Elbow joint (1)
- Electron microscopy (1)
- Ellenberg indicator value for light (1)
- Ellenberg indicator values ; Mixed mountain forest ; Niche model ; Phytosociological databank (1)
- Embryonic stem cell (1)
- Endocytose (1)
- Endoplasmic-Reticulum Stress (1)
- Endothelbarriere Rho-GTPasen (1)
- Endothelial barrier functions (1)
- Endothelzelle (1)
- Endothelzelllinie (1)
- Enterisches Nervensystem (1)
- Entwicklung (1)
- Enzyme (1)
- Enzyme-Linked Immunospot assay (ELISPOT) (1)
- Epac (1)
- Epidermal papillae (1)
- Epidermis (1)
- Epithel (1)
- Exosom <Vesikel> (1)
- Exosomes (1)
- Experimental autoimmune encephalomyelitis (1)
- Experimentelle Autoimmune Enzephalomyelitis (1)
- Experimentelle autoimmune Encephalomyelitis (1)
- Experimentelle autoimmune Enzepahlomyelitis (1)
- Expressionsmessungen (1)
- Extracellular Vesicles (1)
- FGF (1)
- FGF/FGFR signalling (1)
- FGFR (1)
- FGFR signaling (1)
- FHA domain (1)
- FHA-Domäne (1)
- Festuco-Brometea (1)
- Fettsucht (1)
- Fibroblastenwachstumsfaktor (1)
- Ficaria ambigua (1)
- G-protein-coupled receptor (1)
- GLT1a (1)
- GLT1v (1)
- GLUT1 (1)
- GLUT3 (1)
- GLUT4 (1)
- GLUT5 (1)
- Garchinger Heide (1)
- Gefäßwand (1)
- Gefäßwand residente Stammzellen (1)
- Gefäßwand-residente Stamm- und Vorläuferzellen (1)
- Gefäßwand-residente Stammzellen (1)
- Gehirn (1)
- Genexpression (1)
- Genom (1)
- Genome Editing (1)
- Gentianaviolett (1)
- Geruch (1)
- Geruchssystem (1)
- Geschmacksrezeptor (1)
- Glucocorticoid-responsives Element (1)
- Glucocorticosteroide (1)
- Glucocorticosteroidrezeptor (1)
- Glukokortikoide (1)
- Glukosetransporter -1 (1)
- Glutamat (1)
- Glutamate transporters (1)
- Glutamatergic synapses (1)
- Gold-Hahnenfuß (1)
- Guinea-pig uterus (1)
- Gustducin (1)
- HCMV infection (1)
- Hahnenfuß (1)
- Hematopoietic Stem (1)
- Heme-regulated inhibitor (1)
- Herzinfarkt (1)
- Herzmuskelzelle (1)
- Hieracium auriculoides (1)
- Hieracium cymosum (1)
- Hieracium echioides (1)
- Hieracium lachenalii subsp. litocretaceum (1)
- Hieracium maculatum (1)
- Hieracium subrigidum (1)
- Hieracium swantevitii (1)
- Hippocampus (1)
- Hirnendothelzellen (1)
- Hitzeschockprotein (1)
- Homologieklonierung (1)
- Hornkraut (1)
- Hueter interval (1)
- Human Muse Cells (1)
- Hypertonie (1)
- II type-2 receptor (1)
- IL-6 (1)
- IL6 (1)
- Immun-Checkpoint (1)
- Immune tolerance (1)
- Immunozyt (1)
- Immunsystem (1)
- Immunzytochemie (1)
- In-situ-Hybridisierung (1)
- Induction (1)
- Induzierte pluripotente Stammzelle (1)
- Inflammation (1)
- Intermediate filaments (1)
- Ionentransport (1)
- Ischämie (1)
- Ischämie-Reperfusions-Schaden (1)
- KATP channel (1)
- Kapillararchitektur (1)
- Kapillare (1)
- Kapillarwand-assoziierte Zellen (1)
- Kardioonkologie (1)
- Kationentransporter 1 der Ratte (1)
- Keimzellentwicklung (1)
- Kern (1)
- Kernproteine (1)
- Kettenblume (1)
- Kidney (1)
- Klee (1)
- Kleinhirn (1)
- Knockout <Molekulargenetik> (1)
- Kohl (1)
- Kollagen (1)
- Kollageninhibition (1)
- Kombinationstherapie (1)
- Konfokale Mikroskopie (1)
- Konformationsänderungen (1)
- Koronararterie (1)
- Kraft-Frequenz-Beziehung (1)
- Kuhblume (1)
- Küstenschutz (1)
- L cells (1)
- L-typ Calciumkanal Antagonist (1)
- LINGO-1 (1)
- LPS (1)
- Lacking neurofilaments (1)
- Lamin (1)
- Lamin A (1)
- Lamine (1)
- Langhaariges Habichtskraut (1)
- Latrophilin (1)
- Lectotypus (1)
- Lokalisierung (1)
- Lower Francony (1)
- Luftröhre (1)
- Luftröhrenschleimhaut (1)
- Lymphoide Neogenese (1)
- Lysyl-Oxidase (1)
- Löwenzahn <Taraxacum> (1)
- MAP kinase pathway (1)
- MK801 (1)
- MNV type 3 (1)
- MP4 (1)
- MP4-EAE (1)
- Mactel 2 (1)
- Makrophagen (1)
- Mamma-Karzinom (1)
- Medium spiny neurons (1)
- Meiose (1)
- Membrantransport (1)
- Messenger-RNAs (1)
- Microtubules (1)
- Microvesicles (1)
- Migration (1)
- Mikroglia (1)
- Minoxidil (1)
- Missense mutation (1)
- Mitomycin C (1)
- Molekularbiologie (1)
- Molekulargenetik (1)
- Monosaccharid-abhängig (1)
- Morphology (1)
- Morphotype (1)
- Motoneuron disease (1)
- Motor learning (1)
- Motorisches Lernen (1)
- Mouse model (1)
- Multidetector computed tomography (1)
- Musculus und Ligamentum pterygospinosus (1)
- Muskel (1)
- Mutation (1)
- Mutationanalysis (1)
- Mycobacterium tuberculosis (1)
- Myokard (1)
- Myokardinfarkt (1)
- N-Myc (1)
- NES (1)
- NF-kappa-B (1)
- NMDA-Antagonist (1)
- NMDA-Rezeptor (1)
- NMDAR (1)
- Na+-DGlucosekotransporter (1)
- Na+-glucosecotransporter (1)
- Nachtkerze <Gattung> (1)
- Nanog protein (1)
- Natrium-abhängigen Glukosetransporter-1 (1)
- Nelkengewächse (1)
- Neophyten <Botanik> (1)
- Nervenregeneration (1)
- Nervenwurzelausriss (1)
- Nervenwurzelreplantation (1)
- Nervenzelle (1)
- Nervus Opticus (1)
- Netherlands (1)
- Netzhaut (1)
- Neural Differentiation (1)
- Neurodegeneration (1)
- Neuroendokrine Zellen (1)
- Neurofilament (1)
- Neuropeptid Y (1)
- Neuroregeneration (1)
- Neurotropher Faktor (1)
- Neurotrophic factors (1)
- Niche model (1)
- Nimodipin (1)
- Nomen novum (1)
- Nordtirol (1)
- Northern Bavaria (1)
- Nuclear Import (1)
- OCT1 (1)
- ODC (1)
- OXPHOS (1)
- Oberflächenexpression (1)
- Oct4 (1)
- Oenothera (1)
- Oenothera stucchii (1)
- Okulodentodigitale Dysplasie (1)
- Olfactory system (1)
- Olfaktion (1)
- Olfaktorisches System (1)
- Ontogenese (1)
- Oozyte (1)
- Organic cation transporters (1)
- Organischer Kationentransporter (1)
- Organoid (1)
- Ornithindecarboxylase (1)
- Osteoarthritis (1)
- Osteoarthrose (1)
- PCDHGC3 (1)
- PD-1/PD-L1 (1)
- PDGF (1)
- PDGF- Scherstress- Endothelzellen (1)
- PDGF- sherstress- endothelial cells (1)
- PIK3R1 (1)
- PKB/Akt phosphorylation (1)
- PKC (1)
- PP2A (1)
- PSP (1)
- Parenchym (1)
- Parkinson Krankheit (1)
- Parkinson's disease (1)
- Parkinson’s disease (1)
- Perizyt (1)
- Permeabilität (1)
- Peyer's patches (1)
- Phedimus middendorffianus, var. diffusus (1)
- Phedimus spurius subsp. oppositifolius (1)
- Phenobarbitone (1)
- Phosphorylation (1)
- Phytosociological database (1)
- Pilosella macranthela (1)
- Pilosella ottonis (1)
- Plasma-membrane (1)
- Plasmamembran (1)
- Plasmamembrane (1)
- Plastizität (1)
- Plexus brachialis (1)
- Pluripotency (1)
- Progenitor (1)
- Progeria infantilum (1)
- Progressive motor neuronopathy (1)
- Prostatakarzinom (1)
- Proteasom (1)
- Protein kinase B (1)
- Protein transduction (1)
- Proteinkinase C (1)
- Proteinkinase CK2 (1)
- Pruno-Rubion sprengelii (1)
- Prunus (1)
- Präkonditionierung (1)
- Quality-control (1)
- Quinine (1)
- RAP (1)
- RNA sequencing (1)
- RNA-sequencing (1)
- RNS (1)
- ROS (1)
- Rac (1)
- Rac 1 (1)
- Rac1 (1)
- Ranunculus (1)
- Ranunculus puberulus (1)
- Ranunculus sarntheinianus (1)
- Ranunculus suborbicularis (1)
- Ranunculus vertumnalis (1)
- Rats (1)
- Regeneration niche (1)
- Regulation of SGLT1 (1)
- Regulation von SGLT1 (1)
- Regulatorprotein (1)
- Regulatory T cells (1)
- Regulierung (1)
- Relapsing-remitting MS (1)
- Restriktive Dermopathie (1)
- Retinsäure (1)
- Rhamno-Prunetea (1)
- Rho (1)
- Rho A (1)
- Rho GTPase (1)
- Rho GTPases (1)
- Rho-GTPasen (1)
- Rho-Proteine (1)
- Rictor-mTOR complex (1)
- Rosaceae (1)
- Rosengewächse (1)
- Rubella virus (1)
- Rubus L. sectio Corylifolii (1)
- Rubus boreofrisicus (1)
- Rubus phylloglotta (1)
- Rubus pseudoglotta (1)
- Rubus section (1)
- Rubus viridilucidus (1)
- Rv3034c (1)
- SAP47 gene (1)
- SARS-CoV-2 (1)
- SEMA3A (1)
- SH group (1)
- SH-Gruppen (1)
- SLC22 (1)
- SLC2A3 (1)
- SP-fixation (1)
- SR protein kinase (1)
- SR-Protein Kinase (1)
- SSRE (1)
- Sammelrohr (1)
- Scanning electron microscopy (1)
- Schlaganfall (1)
- Schwann cells (1)
- Sea dikes (1)
- Sedum oppositifolium (1)
- Seedeich (1)
- Sekretion (1)
- Sektion Corylifolii (1)
- Senescence (1)
- Serin-Threonin-Kinase (1)
- Serotonerge Nervenzelle (1)
- Signaltransduktion (1)
- Signalwege (1)
- Signalübertragung (1)
- Skleroproteine (1)
- Sodium dependent glucose transporter-1 (1)
- Species novum (1)
- Spinal Muscular-arthropy (1)
- Standortfaktor <Botanik> (1)
- Stat3 (1)
- Stathmin (1)
- Stem cells (1)
- Stress (1)
- Stressprotein (1)
- Striatum (1)
- Sturkturprotein (1)
- Substance P receptor (1)
- Substrataffinität (1)
- Substratspezifität (1)
- Switzerland (1)
- Syap1 localization (1)
- Synaptic plasticity (1)
- Synaptinemal-Komplex (1)
- Synaptonemalkomplex (1)
- Systematics (1)
- T cell assay (1)
- T cells (1)
- T-Zellen (1)
- T-cadherin (1)
- T1R1 (1)
- T1R2 (1)
- TGF-beta (1)
- TGF-β1 (1)
- TLO (1)
- TNF-α (1)
- TOC (Condylus occipitale tertius) (1)
- TOC (third occipital condyle) (1)
- TTS (1)
- Taraxacum (1)
- Taraxacum cimae-gallinae spec. nov. (1)
- Taraxacum sect. Borealia (1)
- Targeted therapies (1)
- Taste receptor (1)
- Taxane (1)
- Taxanes (1)
- Taxonomie (1)
- Tertiär lymphatische Organe (1)
- Tertiär lymphatisches Organ (1)
- Thüringen (1)
- Tiermodell (1)
- Tight junction (1)
- Titin (1)
- Trachea (1)
- Transcription factor NRF1 (1)
- Transgenic mice (1)
- Translation Initiation (1)
- Transport (1)
- Transporter (1)
- Transporters (1)
- Trifolium dubium (1)
- Trifolium ornithopodioides (1)
- Triple in situ hybridization (1)
- TrkB (1)
- Tumorimmunumgebung (1)
- Tumour angiogenesis (1)
- UBA (1)
- Ubiquitin (1)
- Ultrastruktur (1)
- Unterart (1)
- VAChT (1)
- VE cadherin (1)
- VE-cadherin (1)
- VEGF (1)
- VPP mouse model (1)
- VW-SCs (1)
- Varikositäten (1)
- Vaskularisation (1)
- Vaskularisierung (1)
- Verbreitung (1)
- Verteilung (1)
- Vesikel (1)
- Viability (1)
- W355 (1)
- W359 (1)
- WNT signaling (1)
- Weißtanne (1)
- X-ray computed (1)
- XBP1 (1)
- Xenopus laevis (1)
- Y-gastric bypass (1)
- Zell-Adhäsionsmolekül (1)
- Zellkommunikation (1)
- Zellkontakt (1)
- Zellkontakte (1)
- Zellkontaktproteine (1)
- Zellkultur (1)
- Zellskelett (1)
- Zellzyklus (1)
- Zuckeraufnahme (1)
- Zytokeratine (1)
- Zytoskelett (1)
- aB-Crystallin (1)
- aB-crystallin (1)
- aPC (1)
- abdominal imaging (1)
- acceptance (1)
- acetylcholine (1)
- acetyltransferase (1)
- acinic cell carcinoma (1)
- activation (1)
- adenocarcinoma (1)
- adenoid cystic carcinoma (ACC) (1)
- adherens tight junctions (1)
- adhesion GPCR (1)
- adhesion molecule-1 (1)
- adipose tissue (1)
- adipose-derived stromal cells (1)
- adventitia (1)
- age-related macular degeneration (1)
- age-related macular degeneration (AMD) (1)
- agricultural landscape (1)
- aktive Zone (1)
- alpha-B-Crystallin (1)
- alpine Taraxaca (1)
- anatomical landmark (1)
- angiotensin II (1)
- antibodies (1)
- anti‐aging (1)
- anxiety (1)
- aorta ring (1)
- aortic adventitia (1)
- apoptosis (1)
- assembloid (1)
- astrocytoma (1)
- asymmetry (1)
- atherosclerosis (1)
- atrial natriuretic peptide (1)
- autoimmunity (1)
- axonal damage (1)
- axonal degeneration (1)
- axonal injury (1)
- axons (1)
- beta-aminopropionitrile (1)
- bile duct (1)
- biliary glycoprotein CD66A (1)
- biliopancreatic diversion (1)
- biodiversity (1)
- biomedicine (1)
- bioprinting (1)
- bioprocessing (1)
- blood coagulation (1)
- blood pressure (1)
- blood-brain barrier (1)
- blood-brain barrier (BBB) model (1)
- blood-brain-barrier (1)
- body weight (1)
- bone marrow-derived monocytes (1)
- brain capillary endothelial cells (1)
- brain endothelial cell line (1)
- brain-retina axis (1)
- breast cancer (1)
- breast cancer cells (1)
- breast cancer model (1)
- brilliant green (1)
- brush cell (1)
- brush cells (1)
- c-Myc (1)
- cAMP (1)
- cable-clamp implants (1)
- cadherin-13 (CDH13) (1)
- cadherins (1)
- calcareous grassland (1)
- calcitonin gene-related peptide (1)
- calcium channel antagonists (1)
- calodon (1)
- cancellous bone (1)
- cancer (1)
- cancer therapy (1)
- carcinoembryonic anitgen family (1)
- cardiac hyperthrophy (1)
- catalase (1)
- cation transporter (1)
- caveolin-1 (1)
- cell adhesion proteins (1)
- cell biology (1)
- cell cycle (1)
- cell penetrating peptides (1)
- cells (1)
- cellular internalization (1)
- cerebEND (1)
- cerebellar granule cells (1)
- cerebral microvasculature (1)
- characterisation (1)
- chemistry (1)
- chemotherapy (CH) (1)
- chimeras (1)
- cholinergic (1)
- choroidal neovascularization (CNV) (1)
- chromatin (1)
- chronic kidney disease (1)
- chronic viral infection (1)
- ciliary neurotrophic factor (CNTF) (1)
- classification (1)
- climate (1)
- coexpression (1)
- coiled-coil (1)
- confluence (1)
- contacts (1)
- contextual anxiety (1)
- contractility (1)
- convolution kernel (1)
- cortical pathology (1)
- corticosterone (1)
- cotransporter SGLT1 (1)
- cytokine secretion kinetics (1)
- cytokines (1)
- cytomegalovirus (1)
- cytotopes (1)
- dCIRL (1)
- dandelion (1)
- degeneration (1)
- demyelination (1)
- dendric cells (1)
- desmosomal cadherins (1)
- desmosomes (1)
- determination key (1)
- development (1)
- developmental biology (1)
- dexamethasone (1)
- diabetes mellitus (1)
- diagnostic markers (1)
- dilated cardiomyopathy with ataxia (1)
- direct anterior approach (1)
- disability (1)
- disease (1)
- distinction (1)
- distribution range (1)
- diversity (1)
- dorsal raphe (1)
- dovitinib (1)
- drug transport (1)
- duodenal jejunal bypass (1)
- early neural precursors (1)
- ecology (1)
- editorial (1)
- elispot (1)
- embryonic stem cells (1)
- endocytosis (1)
- endotelium (1)
- endothelial barrier (1)
- endothelial cell infection (1)
- enteroendocrine cells (1)
- enzyme-linked immunoassays (1)
- epithelial cells (1)
- epithelial salivary gland (1)
- euchaetium (1)
- ex-arable field (1)
- exhaustion (1)
- exocytosis (1)
- exocytotic pathway (1)
- experimentelle autoimmune Enzephalomyelitis (1)
- expression messurements (1)
- extinction (1)
- extracellular loop (1)
- extracellular matrix disorganisation (1)
- extrazelluläre Schleife (1)
- extrusion of hiMPC-containing bioinks alginate + collagen type I (1)
- factor XII (1)
- factor binding profiles (1)
- fallax (1)
- false tongue-leaf blackberry (1)
- fear conditioning (1)
- fentanyl (1)
- ferroptosis (1)
- fibroblastenwachstumsfaktor-rezeptor (1)
- fingolimod (1)
- flora (1)
- food intake (1)
- force frequency relationship (1)
- fracture (1)
- fructose intolerance (1)
- frühe neurale Vorläufer (1)
- functional characterization (1)
- gall bladder (1)
- gene expression (1)
- gene locus (1)
- genetics (1)
- genome (1)
- genome size (1)
- gentian violett (1)
- germ cell development (1)
- glioblastoma multiforme (1)
- glioma (1)
- glucagon like peptide-1 (1)
- glucagon-like peptide-1 (GLP-1) (1)
- glucocorticoid-response element (1)
- glucokinase (1)
- glucose transporter (1)
- glucose-galactose malabsorption (1)
- glucosetransporter (1)
- glut1 (1)
- glutamate (1)
- glutamate transporter (1)
- growth-factor (1)
- gut bacteria (1)
- gut hormones (1)
- hACE2 (1)
- hcv infection (1)
- heart failure (1)
- heart-brain axis (1)
- heat shock protein (1)
- hematopoietic (1)
- hematopoietic stem cells (1)
- high contrast (1)
- hip replacement (1)
- hippocampus (1)
- histone H1 (1)
- homebox genes (1)
- homeodomain transcription factors (1)
- homology cloning (1)
- human (1)
- human cytomegalovirus (HCMV) (1)
- human endothelial cells (1)
- human iPSC-derived mesodermal cells (hiMPCs) (1)
- human induced pluripotent stem cells (hiPSCs)human induced pluripotent stem cells (hiPSCs) (1)
- human neurons (1)
- human osteosarcoma xenografts (1)
- human primary cells (1)
- humanen induzierte pluripotente Stammzellen (1)
- hyaluronic acid (1)
- hydrostatischer Druck (1)
- hypertonic solution (1)
- hypoxia (1)
- hypoxia inducible factor 1 (1)
- iconography (1)
- immuncytochemistry (1)
- immune response (1)
- immunofluorescence (1)
- immunosenescence (1)
- immunotherapy (1)
- in situ Hybridisierung (1)
- in-situ hybridization (1)
- induced neural stem cells (1)
- inflammatory diseases (1)
- influenza virus ; virion RNA segments ; oligonucleotide mapping ; gene reassortment (1)
- innate immunity (1)
- insulin signaling (1)
- integrin α5β1 (1)
- integrin αvβ3 (1)
- interferon beta-1a (1)
- interleukin-1β (1)
- internalization (1)
- intestinal glucose (1)
- intestine (1)
- intraoperative radiotherapy (1)
- ischemia reperfusion injury (1)
- ischemic stroke (1)
- isosteviol sodium (STVNA) (1)
- kAE1 (1)
- kanadaptin (1)
- karyotypes (1)
- keratinocytes (1)
- l-type calcium channel antagonist (1)
- lamin A (1)
- leukemia inhibitory factor (1)
- lipids (1)
- localisation (1)
- lung (1)
- lung fibrosis (1)
- lymphogene Metastasenbildung (1)
- macular neovascularization (1)
- management (1)
- markers (1)
- mechanotransduction (1)
- megakaryocytes (1)
- meiosis (1)
- membrane transport (1)
- membrane vesicles (1)
- memory cells (1)
- meninges (1)
- mesenchymal stem cells (1)
- mesenchymal stromal cells (1)
- mesodermal (1)
- mesodermal organoid (1)
- metabolism (1)
- metabotropic signalling (1)
- microRNA (1)
- microvascular complications (1)
- microvasculature (1)
- microvessel permeability (1)
- migration (1)
- minimally-invasive (1)
- model (1)
- molecular biology (1)
- monocytes (1)
- monosaccharide-dependent (1)
- morphotypes (1)
- mouse model (1)
- mouse models (1)
- mucociliary clearance (1)
- multilayered vessel wall with intimate, media and adventitia (1)
- multipotent fetal neural stem cells (fNSCs) (1)
- muscle (1)
- mutagenesis (1)
- mutation analysis (1)
- mutational analysis (1)
- mutationen (1)
- mutations (1)
- myelin (1)
- myeloid (1)
- myeloid cells (1)
- myocardial infarction (1)
- myocardium (1)
- natural history (1)
- neonatales Pemphigus-Maus-Modell (1)
- neotype (1)
- nerve fibers (1)
- nerve regneration (1)
- nerve root avulsion (1)
- nervous system (1)
- neue Brombeerart (1)
- neural crest (1)
- neural organoid (1)
- neurites varicosities (1)
- neuro-/photoreceptor degeneration (1)
- neurodevelopment (1)
- neuroendocrine cells (1)
- neuroepithelial progenitors (1)
- neuroepitheliale Vorläufer (1)
- neurogenic (1)
- neuroimmunology (1)
- neuropeptide Y (1)
- neuroprotective pathways (1)
- neuroregeneration (1)
- neurotrophe Faktoren (1)
- neurotrophic facors (1)
- neurotrophic factors (1)
- neurovascular unit in vitro (1)
- new Rubus species (1)
- new name (1)
- nicotinic acetylcholine receptors (1)
- nonneuronal acetylcholine (1)
- nuclear export (1)
- nuclear export signal (1)
- nuclear localization sequence (1)
- nuclear localization signal (1)
- nuclear transport (1)
- obesity (1)
- occurrence (1)
- olfaction (1)
- olfactory system (1)
- ontogenesis (1)
- oocyte (1)
- open-access database (1)
- optic nerve (1)
- organic (1)
- organic cation transporter (1)
- organic cations (1)
- organische Kationen (1)
- organischer (1)
- p27(KIP1) (1)
- pancreatic cancer (1)
- parenchyma (1)
- pathology (1)
- pemphigus vulgaris (1)
- penetratin (1)
- perforator (1)
- peripheral nerve (1)
- peripheral nervous system (1)
- peroxisome (1)
- persistant infection (1)
- personalized treatment (1)
- phenotype (1)
- phosphatidylinositol (1)
- phosphocholine (1)
- plasma membrane (1)
- podocytes (1)
- polyamines (1)
- preclinical research (1)
- preconditioning (1)
- prefrontal cortex (1)
- probe level data (1)
- progenitor (1)
- progenitor cells (1)
- progenitors (1)
- proliferation (1)
- proteasome (1)
- protein (1)
- protein conformational changes (1)
- protein phosphorylation (1)
- protein synthesis (1)
- proximal tubule (1)
- proximaler Tubulus (1)
- psychiatric disorders (1)
- psychology (1)
- pterygoalar bars (1)
- pterygospinous complex (1)
- pterygospinous muscle or ligament (1)
- pterygospinöse Strukturen (1)
- pterygospinöser Komplex (1)
- pubic symphysis (1)
- pulmonary hypertension (1)
- rOCT (1)
- rOCT2 (1)
- radial glia (1)
- radiation (1)
- radiotherapy (1)
- rat heart (1)
- reactive oxygen species (1)
- recurrence (1)
- regulatory protein (1)
- renAE1 (1)
- reorganization (1)
- reprogramming (1)
- resident CD34-positive cells (1)
- restrictive dermopathy (1)
- retinal angiomatous proliferation (1)
- retinoic acid (1)
- rhizotomy (1)
- rho GTPases (1)
- salivary (1)
- salivary gland (1)
- salivary gland tumors (1)
- sasculature (1)
- scale-up (1)
- scanning electron micrographs (1)
- self-renewal (1)
- sensory ganglia (1)
- sensory neuron (1)
- sensory physiology (1)
- sepsis (1)
- serial block face EM (1)
- serielle Rasterelektronenmikroskopie (1)
- series Discolores (1)
- series Vestiti (1)
- serotonerges System (1)
- serotonin (1)
- sglt1 (1)
- shear stress fibers (1)
- signal transmission (1)
- signature (1)
- single‐cell RNA‐seq (1)
- small intestine (1)
- sodium channels (1)
- soil nutrients (1)
- solid tumors (1)
- spectral shaping (1)
- spheroids (1)
- spinal cord (1)
- stem cells (1)
- stress (1)
- stress fibers (1)
- stress protein (1)
- structural protein (1)
- substrate affinity (1)
- sugar uptake (1)
- suppressor cells (1)
- suspension culture (1)
- synapse (1)
- synaptic active zone cytomatrix (1)
- synaptic vesicles (1)
- synaptonemal complex (1)
- taste (1)
- taste receptor cells (1)
- taxonomy (1)
- teratocarcinoma cells (1)
- teratokarzinome Zellen (1)
- thrombin (1)
- tight junction (1)
- tin prefiltration (1)
- titin (1)
- tomography (1)
- topsoil removal (1)
- traffiking (1)
- trans-Stimulation (1)
- trans-stimulation (1)
- transcapillary pressure gradient (1)
- transcription-3 (STAT3) (1)
- transinteraction (1)
- transmission electron microscopy (1)
- transport (1)
- transporter (1)
- transporter regulator (1)
- trial (1)
- tube formation (1)
- tuft cells (1)
- tumor (1)
- tumor microenvironment (1)
- tumor spheroids (1)
- tumor-vessel wall-interface model (1)
- tumorigenic properties (1)
- tumors (1)
- ubiquitin (1)
- ultra-low-dose CT (1)
- unfolded protein response (1)
- urinary calculi (1)
- vagus nerve stimulation (1)
- vascular biofabrication (1)
- vascular network and hierarchical organized vessels (1)
- vascular normalization (1)
- vascular wall stem and progenitor cells (1)
- vascularization (1)
- vascularization model (1)
- vasculature (1)
- ventral root replantation (1)
- vesicular acetylcholine transporter (1)
- vessel wall resident stem cells (1)
- viability (1)
- white matter (1)
- xerostomia (1)
- zerebelläre Körnerzellen (1)
- zerebrale Mikrovaskulatur (1)
- µ-Opioid receptor (1)
- Ökologie (1)
- Österreich (1)
- β-Aminopropionitril (1)
Institute
- Institut für Anatomie und Zellbiologie (266) (remove)
Sonstige beteiligte Institutionen
- Department of Biomedical Imaging, National Cerebral and Cardiovascular Research Center, Suita, Japan (2)
- Division of Medical Technology and Science, Department of Medical Physics and Engineering, Course of Health Science, Osaka University Graduate School of Medicine, Suita Japan (2)
- Institut for Molecular Biology and CMBI, Department of Genomics, Stem Cell Biology and Regenerative Medicine, Leopold-Franzens-University Innsbruck, Innsbruck, Austria (2)
- Johns Hopkins School of Medicine, The Russell H Morgan Department of Radiology and Radiological Science, Baltimore, MD, USA (2)
- Naturalis Biodiversity Centre (2)
- Johns Hopkins School of Medicine (1)
- Johns Hopkins School of Medicine, Baltimore, MD, U.S. (1)
Pemphigus vulgaris (PV) ist eine blasenbildende Autoimmunerkrankung, die durch Autoantikörper gegen Dsg1 und Dsg3 gekennzeichnet ist. Der genaue Pathomechanismus, der zu einem PV-IgG vermittelten Verlust der interzellulären Adhäsion führt, ist noch unklar. Die Dsg3-Depletion und die Modulation von Signalkaskaden stellen hierbei kennzeichnende Merkmale der Erkrankung dar. Mit den Ergebnissen der vorliegenden Arbeit ist eine bessere Einordnung der Dsg3-Depletion in den pathogenetischen Kontext von Pemphigus vulgaris möglich. Die Experimente zeigen, dass die Dsg3-Depletion von Differenzierungsprozessen abhängig ist und mit einem Adhäsionsverlust einhergehen kann. Die Hemmung der PKC verhindert hierbei sowohl die PV-IgG vermittelten Effekte in der Zellkultur als auch die Blasenbildung im Mausmodell in vivo und in humaner Haut ex vivo. Des Weiteren liefert die Arbeit neue Erkenntnisse, welche für die suprabasale Lokalisation der Blasenbildung bedeutsam sein könnten.
Fibroblast growth factor (FGF) signaling is involved in the pathogenesis of multiple sclerosis (MS). Data from neuropathology studies suggest that FGF signaling contributes to the failure of remyelination in MS. In MOG\(_{35–55}\)-induced EAE, oligodendrocyte-specific deletion of FGFR1 and FGFR2 resulted in a less severe disease course, reduced inflammation, myelin and axon degeneration and changed FGF/FGFR and BDNF/TrkB signaling. Since signaling cascades in oligodendrocytes could not be investigated in the EAE studies, we here aimed to characterize FGFR-dependent oligodendrocyte-specific signaling in vitro. FGFR inhibition was achieved by application of the multi-kinase-inhibitor dovitinib and the FGFR1/2/3-inhibitor AZD4547. Both substances are potent inhibitors of FGF signaling; they are effective in experimental tumor models and patients with malignancies. Effects of FGFR inhibition in oligodendrocytes were studied by immunofluorescence microscopy, protein and gene analyses. Application of the tyrosine kinase inhibitors reduced FGFR1, phosphorylated ERK and Akt expression, and it enhanced BDNF and TrkB expression. Furthermore, the myelin proteins CNPase and PLP were upregulated by FGFR inhibition. In summary, inhibition of FGFR signaling in oligodendrocytes can be achieved by application of tyrosine kinase inhibitors. Decreased phosphorylation of ERK and Akt is associated with an upregulation of BDNF/TrkB signaling, which may be responsible for the increased production of myelin proteins. Furthermore, these data suggest that application of FGFR inhibitors may have the potential to promote remyelination in the CNS.
Biofabrication, including printing technologies, has emerged as a powerful approach to the design of disease models, such as in cancer research. In breast cancer, adipose tissue has been acknowledged as an important part of the tumor microenvironment favoring tumor progression. Therefore, in this study, a 3D-printed breast cancer model for facilitating investigations into cancer cell-adipocyte interaction was developed. First, we focused on the printability of human adipose-derived stromal cell (ASC) spheroids in an extrusion-based bioprinting setup and the adipogenic differentiation within printed spheroids into adipose microtissues. The printing process was optimized in terms of spheroid viability and homogeneous spheroid distribution in a hyaluronic acid-based bioink. Adipogenic differentiation after printing was demonstrated by lipid accumulation, expression of adipogenic marker genes, and an adipogenic ECM profile. Subsequently, a breast cancer cell (MDA-MB-231) compartment was printed onto the adipose tissue constructs. After nine days of co-culture, we observed a cancer cell-induced reduction of the lipid content and a remodeling of the ECM within the adipose tissues, with increased fibronectin, collagen I and collagen VI expression. Together, our data demonstrate that 3D-printed breast cancer-adipose tissue models can recapitulate important aspects of the complex cell–cell and cell–matrix interplay within the tumor-stroma microenvironment
Operative treatment of ruptured pubic symphysis by plating is often accompanied by complications. Trans-obturator cable fixation might be a more reliable technique; however, have not yet been tested for stabilization of ruptured pubic symphysis. This study compares symphyseal trans-obturator cable fixation versus plating through biomechanical testing and evaluates safety in a cadaver experiment. APC type II injuries were generated in synthetic pelvic models and subsequently separated into three different groups. The anterior pelvic ring was fixed using a four-hole steel plate in Group A, a stainless steel cable in Group B, and a titan band in Group C. Biomechanical testing was conducted by a single-leg-stance model using a material testing machine under physiological load levels. A cadaver study was carried out to analyze the trans-obturator surgical approach. Peak-to-peak displacement, total displacement, plastic deformation and stiffness revealed a tendency for higher stability for trans-obturator cable/band fixation but no statistical difference to plating was detected. The cadaver study revealed a safe zone for cable passage with sufficient distance to the obturator canal. Trans-obturator cable fixation has the potential to become an alternative for symphyseal fixation with less complications.
Effects of dopamine on BDNF / TrkB mediated signaling and plasticity on cortico-striatal synapses
(2021)
Progressive loss of voluntary movement control is the central symptom of Parkinson's disease (PD). Even today, we are not yet able to cure PD. This is mainly due to a lack of understanding the mechanisms of movement control, network activity and plasticity in motor circuits, in particular between the cerebral cortex and the striatum. Brain-derived neurotrophic factor (BDNF) has emerged as one of the most important factors for the development and survival of neurons, as well as for synaptic plasticity. It is thus an important target for the development of new therapeutic strategies against neurodegenerative diseases. Together with its receptor, the Tropomyosin receptor kinase B (TrkB), it is critically involved in development and function of the striatum. Nevertheless, little is known about the localization of BDNF within presynaptic terminals in the striatum, as well as the types of neurons that produce BDNF in the cerebral cortex. Furthermore, the influence of midbrain derived dopamine on the control of BDNF / TrkB interaction in striatal medium spiny neurons (MSNs) remains elusive so far. Dopamine, however, appears to play an important role, as its absence leads to drastic changes in striatal synaptic plasticity. This suggests that dopamine could regulate synaptic activity in the striatum via modulation of BDNF / TrkB function. To answer these questions, we have developed a sensitive and reliable protocol for the immunohistochemical detection of endogenous BDNF. We find that the majority of striatal BDNF is provided by glutamatergic, cortex derived afferents and not dopaminergic inputs from the midbrain. In fact, we found BDNF in cell bodies of neurons in layers II-III and V of the primary and secondary motor cortex as well as layer V of the somatosensory cortex. These are the brain areas that send dense projections to the dorsolateral striatum for control of voluntary movement. Furthermore, we could show that these projection neurons significantly downregulate the expression of BDNF during the juvenile development of mice between 3 and 12 weeks.
In parallel, we found a modulatory effect of dopamine on the translocation of TrkB to the cell surface in postsynaptic striatal Medium Spiny Neurons (MSNs). In MSNs of the direct pathway (dMSNs), which express dopamine receptor 1 (DRD1), we observed the formation of TrkB aggregates in the 6-hydroxydopamine (6-OHDA) model of PD. This suggests that DRD1 activity controls TrkB surface expression in these neurons. In contrast, we found that DRD2 activation has opposite effects in MSNs of the indirect pathway (iMSNs). Activation of DRD2 promotes a rapid decrease in TrkB surface expression which was reversible and depended on cAMP. In parallel, stimulation of DRD2 led to induction of phospho-TrkB (pTrkB). This effect was significantly slower than the effect on TrkB surface expression and indicates that TrkB is transactivated by DRD2. Together, our data provide evidence that dopamine triggers dual modes of plasticity on striatal MSNs by acting on TrkB surface expression in DRD1 and DRD2 expressing MSNs. This surface expression of the receptor is crucial for the binding of BDNF, which is released from corticostriatal afferents. This leads to the induction of TrkB-mediated downstream signal transduction cascades and long-term potentiation (LTP). Therefore, the dopamine-mediated translocation of TrkB could be a mediator that modulates the balance between dopaminergic and glutamatergic signaling to allow synaptic plasticity in a spatiotemporal manner. This information and the fact that TrkB is segregated to persistent aggregates in PD could help to improve our understanding of voluntary movement control and to develop new therapeutic strategies beyond those focusing on dopaminergic supply.
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide and encompasses chronic bronchitis and emphysema. It has been shown that vascular wall remodeling and pulmonary hypertension (PH) can occur not only in patients with COPD but also in smokers with normal lung function, suggesting a causal role for vascular alterations in the development of emphysema. Mechanistically, abnormalities in the vasculature, such as inflammation, endothelial dysfunction, imbalances in cellular apoptosis/proliferation, and increased oxidative/nitrosative stress promote development of PH, cor pulmonale, and most probably pulmonary emphysema. Hypoxemia in the pulmonary chamber modulates the activation of key transcription factors and signaling cascades, which propagates inflammation and infiltration of neutrophils, resulting in vascular remodeling. Endothelial progenitor cells have angiogenesis capabilities, resulting in transdifferentiation of the smooth muscle cells via aberrant activation of several cytokines, growth factors, and chemokines. The vascular endothelium influences the balance between vaso-constriction and -dilation in the heart. Targeting key players affecting the vasculature might help in the development of new treatment strategies for both PH and COPD. The present review aims to summarize current knowledge about vascular alterations and production of reactive oxygen species in COPD. The present review emphasizes on the importance of the vasculature for the usually parenchyma-focused view of the pathobiology of COPD.
Post-fabrication formation of a proper vasculature remains an unresolved challenge in bioprinting. Established strategies focus on the supply of the fabricated structure with nutrients and oxygen and either rely on the mere formation of a channel system using fugitive inks or additionally use mature endothelial cells and/or peri-endothelial cells such as smooth muscle cells for the formation of blood vessels in vitro. Functional vessels, however, exhibit a hierarchical organization and multilayered wall structure that is important for their function. Human induced pluripotent stem cell-derived mesodermal progenitor cells (hiMPCs) have been shown to possess the capacity to form blood vessels in vitro, but have so far not been assessed for their applicability in bioprinting processes. Here, we demonstrate that hiMPCs, after formulation into an alginate/collagen type I bioink and subsequent extrusion, retain their ability to give rise to the formation of complex vessels that display a hierarchical network in a process that mimics the embryonic steps of vessel formation during vasculogenesis. Histological evaluations at different time points of extrusion revealed the initial formation of spheres, followed by lumen formation and further structural maturation as evidenced by building a multilayered vessel wall and a vascular network. These findings are supported by immunostainings for endothelial and peri-endothelial cell markers as well as electron microscopic analyses at the ultrastructural level. Moreover, endothelial cells in capillary-like vessel structures deposited a basement membrane-like matrix at the basal side between the vessel wall and the alginate-collagen matrix. After transplantation of the printed constructs into the chicken chorioallantoic membrane (CAM) the printed vessels connected to the CAM blood vessels and get perfused in vivo. These results evidence the applicability and great potential of hiMPCs for the bioprinting of vascular structures mimicking the basic morphogenetic steps of de novo vessel formation during embryogenesis.
Cone-beam computed tomography is a powerful tool for 3D imaging of the appendicular skeleton, facilitating detailed visualization of bone microarchitecture. This study evaluated various combinations of acquisition and reconstruction parameters for the cone-beam CT mode of a twin robotic x-ray system in cadaveric wrist and elbow scans, aiming to define the best possible trade-off between image quality and radiation dose. Images were acquired with different combinations of tube voltage and tube current–time product, resulting in five scan protocols with varying volume CT dose indices: full-dose (FD; 17.4 mGy), low-dose (LD; 4.5 mGy), ultra-low-dose (ULD; 1.15 mGy), modulated low-dose (mLD; 0.6 mGy) and modulated ultra-low-dose (mULD; 0.29 mGy). Each set of projection data was reconstructed with three convolution kernels (very sharp [Ur77], sharp [Br69], intermediate [Br62]). Five radiologists subjectively assessed the image quality of cortical bone, cancellous bone and soft tissue using seven-point scales. Irrespective of the reconstruction kernel, overall image quality of every FD, LD and ULD scan was deemed suitable for diagnostic use in contrast to mLD (very sharp/sharp/intermediate: 60/55/70%) and mULD (0/3/5%). Superior depiction of cortical and cancellous bone was achieved in FD\(_{Ur77}\) and LD\(_{Ur77}\) examinations (p < 0.001) with LD\(_{Ur77}\) scans also providing favorable bone visualization compared to FD\(_{Br69}\) and FD\(_{Br62}\) (p < 0.001). Fleiss’ kappa was 0.618 (0.594–0.641; p < 0.001), indicating substantial interrater reliability. In this study, we demonstrate that considerable dose reduction can be realized while maintaining diagnostic image quality in upper extremity joint scans with the cone-beam CT mode of a twin robotic x-ray system. Application of sharper convolution kernels for image reconstruction facilitates superior display of bone microarchitecture.
Die Multiple Sklerose (MS) ist eine chronisch-entzündliche Autoimmunerkrankung des zentralen Nervensystems (ZNS) und stellt die häufigste Ursache frühzeitiger Behinderung junger Erwachsener dar. Kennzeichnend sind multifokale ZNS-Läsionen, die durch Inflammation, Demyelinisierung und Axonschäden geprägt sind und zu multiplen neurologischen Defiziten führen. Derzeit ist es mithilfe der verlaufsmodifizierenden Therapie möglich, die Immunantwort abzuschwächen und damit die Krankheitsprogression zu verzögern. Geheilt werden kann die Erkrankung jedoch bislang nicht. Dabei ist nicht hinreichend geklärt, ob die neuen Therapieoptionen über die Immunmodulation/-suppression hinaus einen anhaltenden Schutz vor der langfristigen Neurodegeneration bieten.
Basierend auf den vielversprechenden Ergebnissen klinischer Studien zur Therapie der schubförmig-remittierenden MS mit dem Anti-CD52-Antikörper Alemtuzumab, der zu einer Depletion CD52-exprimierender Immunzellen führt, wurden diesbezüglich Analysen in MS-Tiermodellen durchgeführt. Da die Untersuchung der zugrunde liegenden Patho- und Effektormechanismen am Menschen kaum möglich ist, ist die MS-Forschung für ein tiefergehendes Verständnis auf Tiermodelle angewiesen. Die experimentelle autoimmune Enzephalomyelitis (EAE) ist hierbei das am weitesten verbreitete Modell der MS, wofür vor allem der C57BL/6 (B6) -Mausstamm verwendet wird, da auf diesem Hintergrund die meisten genmodifizierten Mäuse gezüchtet werden. Jene tierexperimentellen Studien, in denen ein muriner Anti-CD52-Antikörper im frühen Krankheitsstadium der EAE (Auftreten erster paralytischer Symptome) verabreicht wurde, erbrachten den Hinweis einer neuroprotektiven und scheinbar regenerativen Wirkung des Antikörpers.
Über einen neuroprotektiven Effekt von Alemtuzumab im schwer behandelbaren chronisch-progredienten Stadium der MS ist jedoch wenig bekannt. Die vorliegende Arbeit ist die erste detaillierte Untersuchung zum Einfluss des murinen Anti-CD52-Antikörpers auf die Demyelinisierung, den Axonschaden und die Hirnatrophie in der MP4-induzierten EAE der B6-Maus im chronischen Verlauf der Erkrankung (ab stabilem Plateau der klinischen Symptomatik). MP4 ist ein Myelinfusionsprotein aus MBP (Myelin-Basisches-Protein) und PLP (Proteolipidprotein), welches in B6-Mäusen durch aktive Immunisierung eine EAE induziert, die chronisch verläuft und als eines von wenigen Modellen neben der T-Zell-Abhängigkeit die an Bedeutung zunehmende B-Zell-Komponente der MS darstellt. Histopathologisch finden sich in der chronischen MP4-induzierten EAE eine ausgeprägte Rückenmarks- und Kleinhirnschädigung, die vor allem im Kleinhirn durch eine B-Zell-Aggregation charakterisiert ist.
Nachdem die MP4-immunisierten Mäuse im chronischen Stadium der EAE an fünf aufeinanderfolgenden Tagen mit 10 mg/kg Körpergewicht murinem Anti-CD52-spezifischem IgG2a-Isotypantikörper bzw. murinem unspezifischem IgG2a-Isotyp-Kontroll-Antikörper behandelt worden waren, wurde die Lymphozytendepletion im peripheren Blut durchflusszytometrisch ermittelt und deren Einfluss auf MP4-spezifische Antikörper anhand eines indirekten Enzyme-linked Immunosorbent Assays (ELISAs) untersucht. Als Marker für Axonschäden wurde im Serum vorhandenes phosphoryliertes Neurofilament-Heavy (pNF-H) mithilfe eines indirekten Sandwich-ELISAs quantitativ bestimmt. Rückenmark und Kleinhirn wurden ultrastrukturell auf Veränderungen der Myelinisierung (mittels g-Ratio: Axondurchmesser geteilt durch Gesamtdurchmesser der Nervenfaser) und auf Axonpathologien (verringerter Abstand benachbarter Neurofilamente, axolytische Axone, axonaler Verlust) untersucht. Die Hirnatrophie wurde MRT-basiert gemessen und der klinische Verlauf täglich evaluiert.
Durch die Anti-CD52-Antikörperbehandlung wurde die T- und B-Zellzahl zwar drastisch vermindert, die MP4-spezifische Antikörperproduktion blieb davon jedoch unbeeinträchtigt. Ein günstiger Effekt auf die De- und Remyelinisierung war nicht festzustellen. Das Hirnvolumen und die klinische Präsentation der Mäuse blieben ebenfalls unverändert. Während kein Unterschied der pNF-H-Konzentration zu erkennen war, konnte ultrastrukturell jedoch ein geringerer Axonschaden nachgewiesen werden.
Insgesamt legen diese Ergebnisse nahe, dass der Anti-CD52-Antikörper im chronischen Verlauf der EAE/MS wenig Einfluss auf die neurodegenerativen Prozesse nimmt und die Regeneration nicht fördern kann. Die Ursache liegt vermutlich in der Undurchlässigkeit der Bluthirnschranke für Antikörper sowie dem limitierten Verständnis der Antikörperwirkung im ZNS. Die vorliegende Studie regt somit zur Etablierung von ZNS-wirksamen Antikörpern an und unterstreicht die Bedeutung der Entwicklung von selektiveren neuroprotektiven und remyelinisierungsfördernden Behandlungsansätzen, die eine wertvolle Ergänzung zur verlaufsmodifizierenden Therapie darstellen könnten.
Die Identifizierung endogener Stammzellen mit kardiogenem Potenzial und die Möglichkeit, deren Differenzierung zu steuern, würde einen Meilenstein in der kardioregenerativen Therapie darstellen. Innerhalb der Gefäßwand konnten unterschiedliche Stamm- und Vorläuferzellen identifiziert werden, die sog. Gefäßwand-residenten Stammzellen (VW-SCs). Zuletzt konnten aus CD34(+) VW-SCs, ohne genetische Manipulation, Kardiomyozyten generiert werden. Zusätzlich fungiert die Gefäßwand als Quelle inflammatorischer Zellen, die essenziell für die kardiogene Differenzierung der VW-SCs zu sein scheinen.
Ziel dieser Arbeit war es, das Verhalten von CD44(+) VW-SCs zu untersuchen, um herauszufinden, inwieweit dieser Stammzelltyp eine endogene Generierung von Kardiomyozyten unterstützen könnte. Dabei wurde mit infarzierten Mäuseherzen, dem Aortenringassay (ARA) und dem kardialen Angiogeneseassay (CAA) gearbeitet.
Sowohl in vivo in ischämischen Arealen infarzierter Mäuseherzen als auch ex vivo im CAA kam es zu einem signifikanten Anstieg von CD44(+) Zellen. Mittels Färbungen auf CD44 und Ki-67 konnte die Teilungsfähigkeit dieser Zellen demonstriert werden.
Ex vivo ließen sich aus CD44(+) Zellen F4/80(+) Makrophagen generieren. Die CD44(+) VW-SCs können sich dabei sowohl zu pro-inflammatorischen iNOS(+) M1- als auch zu anti-inflammatorischen IL-10(+) M2-Makrophagen differenzieren. Eine Modulation der kardialen Inflammation könnte einen entscheidenden Einfluss auf die Kardiomyogenese haben.
Unter VEGF-A kam es im CAA zu einer deutlichen Zunahme von CD44(+) Zellen. Unter Lenvatinib blieb das kardiale Sprouting gänzlich aus, die Anzahl der CD44(+) Zellen stagnierte und die VW-SCs verblieben in ihren physiologischen Nischen innerhalb der Gefäßwand.
Warum es nach einem MI kaum zu einer funktionellen Herzmuskelregeneration kommt, ist weiterhin unklar. Die therapeutische Beeinflussung koronaradventitieller CD44(+) VW-SCs und inflammatorischer Prozesse könnte dabei zukünftig eine wichtige therapeutische Option darstellen.
Salivary gland cancers are rare but aggressive tumors that have poor prognosis and lack effective cure. Of those, parotid tumors constitute the majority. Functioning as metabolic machinery contributing to cellular redox balance, peroxisomes have emerged as crucial players in tumorigenesis. Studies on murine and human cells have examined the role of peroxisomes in carcinogenesis with conflicting results. These studies either examined the consequences of altered peroxisomal proliferators or compared their expression in healthy and neoplastic tissues. None, however, examined such differences exclusively in human parotid tissue or extended comparison to peroxisomal proteins and their associated gene expressions. Therefore, we examined differences in peroxisomal dynamics in parotid tumors of different morphologies. Using immunofluorescence and quantitative PCR, we compared the expression levels of key peroxisomal enzymes and proliferators in healthy and neoplastic parotid tissue samples. Three parotid tumor subtypes were examined: pleomorphic adenoma, mucoepidermoid carcinoma and acinic cell carcinoma. We observed higher expression of peroxisomal matrix proteins in neoplastic samples with exceptional down regulation of certain enzymes; however, the degree of expression varied between tumor subtypes. Our findings confirm previous experimental results on other organ tissues and suggest peroxisomes as possible therapeutic targets or markers in all or certain subtypes of parotid neoplasms.
Ischemic insults to the heart and brain, i.e., myocardial and cerebral infarction, respectively, are amongst the leading causes of death worldwide. While there are therapeutic options to allow reperfusion of ischemic myocardial and brain tissue by reopening obstructed vessels, mitigating primary tissue damage, post-infarction inflammation and tissue remodeling can lead to secondary tissue damage. Similarly, ischemia in retinal tissue is the driving force in the progression of neovascular eye diseases such as diabetic retinopathy (DR) and age-related macular degeneration (AMD), which eventually lead to functional blindness, if left untreated. Intriguingly, the easily observable retinal blood vessels can be used as a window to the heart and brain to allow judgement of microvascular damages in diseases such as diabetes or hypertension. The complex neuronal and endocrine interactions between heart, retina and brain have also been appreciated in myocardial infarction, ischemic stroke, and retinal diseases. To describe the intimate relationship between the individual tissues, we use the terms heart-brain and brain-retina axis in this review and focus on the role of transforming growth factor β (TGFβ) and neurotrophins in regulation of these axes under physiologic and pathologic conditions. Moreover, we particularly discuss their roles in inflammation and repair following ischemic/neovascular insults. As there is evidence that TGFβ signaling has the potential to regulate expression of neurotrophins, it is tempting to speculate, and is discussed here, that cross-talk between TGFβ and neurotrophin signaling protects cells from harmful and/or damaging events in the heart, retina, and brain.
Immunosenescence is considered a possible factor in the development of age-related macular degeneration and choroidal neovascularization (CNV). However, age-related changes of myeloid cells (MCs), such as microglia and macrophages, in the healthy retina or during CNV formation are ill-defined. In this study, Cx3cr1-positive MCs were isolated by fluorescence-activated cell sorting from six-week (young) and two-year-old (old) Cx3cr1\(^{GFP/+}\) mice, both during physiological aging and laser-induced CNV development. High-throughput RNA-sequencing was performed to define the age-dependent transcriptional differences in MCs during physiological aging and CNV development, complemented by immunohistochemical characterization and the quantification of MCs, as well as CNV size measurements. These analyses revealed that myeloid cells change their transcriptional profile during both aging and CNV development. In the steady state, senescent MCs demonstrated an upregulation of factors contributing to cell proliferation and chemotaxis, such as Cxcl13 and Cxcl14, as well as the downregulation of microglial signature genes. During CNV formation, aged myeloid cells revealed a significant upregulation of angiogenic factors such as Arg1 and Lrg1 concomitant with significantly enlarged CNV and an increased accumulation of MCs in aged mice in comparison to young mice. Future studies need to clarify whether this observation is an epiphenomenon or a causal relationship to determine the role of immunosenescence in CNV formation.
SARS-CoV-2 infection can cause fatal inflammatory lung pathology, including thrombosis and increased pulmonary vascular permeability leading to edema and hemorrhage. In addition to the lung, cytokine storm-induced inflammatory cascade also affects other organs. SARS-CoV-2 infection-related vascular inflammation is characterized by endotheliopathy in the lung and other organs. Whether SARS-CoV-2 causes endotheliopathy by directly infecting endothelial cells is not known and is the focus of the present study. We observed 1) the co-localization of SARS-CoV-2 with the endothelial cell marker CD31 in the lungs of SARS-CoV-2-infected mice expressing hACE2 in the lung by intranasal delivery of adenovirus 5-hACE2 (Ad5-hACE2 mice) and non-human primates at both the protein and RNA levels, and 2) SARS-CoV-2 proteins in endothelial cells by immunogold labeling and electron microscopic analysis. We also detected the co-localization of SARS-CoV-2 with CD31 in autopsied lung tissue obtained from patients who died from severe COVID-19. Comparative analysis of RNA sequencing data of the lungs of infected Ad5-hACE2 and Ad5-empty (control) mice revealed upregulated KRAS signaling pathway, a well-known pathway for cellular activation and dysfunction. Further, we showed that SARS-CoV-2 directly infects mature mouse aortic endothelial cells (AoECs) that were activated by performing an aortic sprouting assay prior to exposure to SARS-CoV-2. This was demonstrated by co-localization of SARS-CoV-2 and CD34 by immunostaining and detection of viral particles in electron microscopic studies. Moreover, the activated AoECs became positive for ACE-2 but not quiescent AoECs. Together, our results indicate that in addition to pneumocytes, SARS-CoV-2 also directly infects mature vascular endothelial cells in vivo and ex vivo, which may contribute to cardiovascular complications in SARS-CoV-2 infection, including multipleorgan failure.
Rekrutierung von Stromazellen aus gefäßwandresidenten Vorläuferzellen während der Tumorgenese
(2021)
Tumore bestehen nicht nur aus malignen Zellen, sondern ebenfalls aus einer Vielzahl an nicht tumorigenen Zellen, die den Tumor auf vielfältige Weise unterstützen und den Tumor vor therapeutischen Maßnahmen schützen. Die Frage der Herkunft dieser Zellen insbesondere in einem nicht vaskularisierten Tumor ist daher auch für die Entwicklung zukünftiger Therapeutika relevant. In dieser Arbeit wurde eine Methode etabliert, die im dreidimensionalen Raum die Untersuchung des Einflusses von Tumorzellen auf die vaskuläre Adventitia am Model der Mausaorta ermöglicht. Dazu erfolgte die Einbettung von Alginatbeads aus verschiedenen Tumorzelllinien in eine gemeinsame Kollagenmatrix mit murinen Aortenringen. Während des zehntägigem Versuchszeitraums wurde die Aussprossung von Zellen aus den Aortenringen beobachtet und quantifiziert. Es wurde festgestellt, dass die Auswanderung während des Versuchszeitraums zunimmt und dass die Konfrontation mit der Zytokinmischung der Tumorzellen zu einer stärkeren Aussprossung führt, als die Stimulation mit VEGF oder keine Stimulation. Eine gerichtete Auswanderung der Zellen in Richtung der Tumorbeads konnte nicht nachgewiesen bzw. bestätigt werden. Kapilläre Aussprossungen waren nur in geringem Ausmaß zu beobachten. Bei Charakterisierung der ausgewanderten Zellen mittels immunhistochemischer Färbungen waren keine F4/80-positiven und nur einzelne CD34-positive Zellen zu finden. CD31-positive Endothelzellen stellten die Mehrheit der ausgewanderten Zellen bei Tumorzellkonfrontation. Perizyten, die mit dem Marker NG2 gefärbt wurden, stellten eine Mehrheit der migrierten Zellen bei allen Bedingungen.
Die in dieser Arbeit etablierte Methode des Aortenring-Bead-Konfrontationsassays ermöglicht es, in Echtzeit den Einfluss von Tumorzellen auf die Gefäßwand im dreidimensionalen Raum zu beobachten. Der Aortenring-Bead-Konfrontationsassay bietet eine Vielzahl an Variationsmöglichkeiten und stellt daher eine vielversprechende Möglichkeit dar, die Lücke zwischen zweidimensionalen in vitro-Experimenten und kostenintensiven in vivo-Versuchen zu schließen.
Bei der Autoimmunerkrankung Pemphigus vulgaris führen Antikörper zur charakteristischen suprabasalen Akantholyse und Blasenbildung der Epidermis, indem sie an spezifische Antigene, Dsg3 (Desmoglein 3) und Dsg1 (Desmoglein 1), auf der Zelloberfläche der Keratinozyten binden. Die Art und Weise, wie die multiplen zellulären Pathomechanismen zusammenwirken und das potenziell tödliche Krankheitsbild hervorrufen, ist jedoch bislang noch weitgehend unklar. In der vorliegenden Arbeit wurden entscheidende, durch die Autoantikörper hervorgerufene, pathologische intrazelluläre Prozesse genauer untersucht und deren Stellenwert beleuchtet.
Multiple sclerosis (MS) is a chronic inflammatory and degenerative disease of the central nervous system (CNS). MS commonly affects the cerebellum causing acute and chronic symptoms. Cerebellar signs significantly contribute to clinical disability, and symptoms such as tremor, ataxia, and dysarthria are difficult to treat. Fibroblast growth factors (FGFs) and their receptors (FGFRs) are involved in demyelinating pathologies such as MS. In autopsy tissue from patients with MS, increased expression of FGF1, FGF2, FGF9, and FGFR1 was found in lesion areas. Recent research using mouse models has focused on regions such as the spinal cord, and data on the expression of FGF/FGFR in the cerebellum are not available. In recent EAE studies, we detected that oligodendrocyte-specific deletion of FGFRs results in a milder disease course, less cellular infiltrates, and reduced neurodegeneration in the spinal cord. The objective of this study was to characterize the role of FGFR1 in oligodendrocytes in the cerebellum. Conditional deletion of FGFR1 in oligodendrocytes (Fgfr1\(^{ind−/−}\) was achieved by tamoxifen application, EAE was induced using the MOG\(_{35-55}\) peptide. The cerebellum was analyzed by histology, immunohistochemistry, and western blot. At day 62 p.i., Fgfr1\(^{ind−/−}\) mice showed less myelin and axonal degeneration compared to FGFR1-competent mice. Infiltration of CD3(+) T cells, Mac3(+) cells, B220(+) B cells and IgG(+) plasma cells in cerebellar white matter lesions (WML) was less in Fgfr1\(^{ind−/−}\)mice. There were no effects on the number of OPC or mature oligodendrocytes in white matter lesion (WML). Expression of FGF2 and FGF9 associated with less myelin and axonal degeneration, and of the pro-inflammatory cytokines IL-1β, IL-6, and CD200 was downregulated in Fgfr1\(^{ind−/−}\) mice. The FGF/FGFR signaling protein pAkt, BDNF, and TrkB were increased in Fgfr1\(^{ind−/−}\) mice. These data suggest that cell-specific deletion of FGFR1 in oligodendrocytes has anti-inflammatory and neuroprotective effects in the cerebellum in the EAE disease model of MS.
Megakaryocytes (MKs) release platelets into the lumen of bone marrow (BM) sinusoids while remaining to reside within the BM. The morphogenetic events of this complex process are still not fully understood. We combined confocal laser scanning microscopy with transmission and serial block-face scanning electron microscopy followed by 3D-reconstruction on mouse BM tissue sections. These analyses revealed that MKs in close vicinity to BM sinusoid (BMS) wall first induce the lateral retraction of CXCL12-abundant reticular (CAR) cells (CAR), followed by basal lamina (BL) degradation enabling direct MK-sinusoidal endothelial cells (SECs) interaction. Subsequently, an endothelial engulfment starts that contains a large MK protrusion. Then, MK protrusions penetrate the SEC, transmigrate into the BMS lumen and form proplatelets that are in direct contact to the SEC surface. Furthermore, such processes are induced on several sites, as observed by 3D reconstructions. Our data demonstrate that MKs in interaction with CAR-cells actively induce BMS wall alterations, including CAR-cell retraction, BL degradation, and SEC engulfment containing a large MK protrusion. This results in SEC penetration enabling the migration of MK protrusion into the BMS lumen where proplatelets that are adherent to the luminal SEC surface are formed and contribute to platelet release into the blood circulation.
Although the bone marrow contains most hematopoietic activity during adulthood, hematopoietic stem and progenitor cells can be recovered from various extramedullary sites. Cells with hematopoietic progenitor properties have even been reported in the adult brain under steady‐state conditions, but their nature and localization remain insufficiently defined. Here, we describe a heterogeneous population of myeloid progenitors in the leptomeninges of adult C57BL/6 mice. This cell pool included common myeloid, granulocyte/macrophage, and megakaryocyte/erythrocyte progenitors. Accordingly, it gave rise to all major myelo‐erythroid lineages in clonogenic culture assays. Brain‐associated progenitors persisted after tissue perfusion and were partially inaccessible to intravenous antibodies, suggesting their localization behind continuous blood vessel endothelium such as the blood‐arachnoid barrier. Flt3\(^{Cre}\) lineage tracing and bone marrow transplantation showed that the precursors were derived from adult hematopoietic stem cells and were most likely continuously replaced via cell trafficking. Importantly, their occurrence was tied to the immunologic state of the central nervous system (CNS) and was diminished in the context of neuroinflammation and ischemic stroke. Our findings confirm the presence of myeloid progenitors at the meningeal border of the brain and lay the foundation to unravel their possible functions in CNS surveillance and local immune cell production.
Salivary gland tumors are a rare tumor entity within malignant tumors of all tissues. The most common are malignant mucoepidermoid carcinoma, adenoid cystic carcinoma, and acinic cell carcinoma. Pleomorphic adenoma is the most recurrent form of benign salivary gland tumor. Due to their low incidence rates and complex histological patterns, they are difficult to diagnose accurately. Malignant tumors of the salivary glands are challenging in terms of differentiation because of their variability in histochemistry and translocations. Therefore, the primary goal of the study was to review the current literature to identify the recent developments in histochemical diagnostics and translocations for differentiating salivary gland tumors.
Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the central nervous system (CNS) affecting more than two million people worldwide. In MS, oligodendrocytes and myelin sheaths are destroyed by autoimmune-mediated inflammation, while remyelination is impaired. Recent investigations of post-mortem tissue suggest that Fibroblast growth factor (FGF) signaling may regulate inflammation and myelination in MS. FGF2 expression seems to correlate positively with macrophages/microglia and negatively with myelination; FGF1 was suggested to promote remyelination. In myelin oligodendrocyte glycoprotein (MOG)\(_{35–55}\)-induced experimental autoimmune encephalomyelitis (EAE), systemic deletion of FGF2 suggested that FGF2 may promote remyelination. Specific deletion of FGF receptors (FGFRs) in oligodendrocytes in this EAE model resulted in a decrease of lymphocyte and macrophage/microglia infiltration as well as myelin and axon degeneration. These effects were mediated by ERK/Akt phosphorylation, a brain-derived neurotrophic factor, and downregulation of inhibitors of remyelination. In the first part of this review, the most important pharmacotherapeutic principles for MS will be illustrated, and then we will review recent advances made on FGF signaling in MS. Thus, we will suggest application of FGFR inhibitors, which are currently used in Phase II and III cancer trials, as a therapeutic option to reduce inflammation and induce remyelination in EAE and eventually MS.
Fibroblast growth factors (FGFs) and their receptors (FGFRs) are involved in demyelinating pathologies including multiple sclerosis (MS). In our recent study, oligodendrocyte‐specific deletion of FGFR1 resulted in a milder disease course, less inflammation, reduced myelin and axon damage in EAE. The objective of this study was to elucidate the role of oligodendroglial FGFR2 in MOG\(_{35-55}\)‐induced EAE. Oligodendrocyte‐specific knockout of FGFR2 (Fgfr2\(^{ind-/-}\)) was achieved by application of tamoxifen; EAE was induced using the MOG\(_{35-55}\) peptide. EAE symptoms were monitored over 62 days. Spinal cord tissue was analysed by histology, immunohistochemistry and western blot. Fgfr2\(^{ind-/-}\) mice revealed a milder disease course, less myelin damage and enhanced axonal density. The number of oligodendrocytes was not affected in demyelinated areas. However, protein expression of FGFR2, FGF2 and FGF9 was downregulated in Fgfr2\(^{ind-/-}\) mice. FGF/FGFR dependent signalling proteins were differentially regulated; pAkt was upregulated and pERK was downregulated in Fgfr2\(^{ind-/-}\) mice. The number of CD3(+) T cells, Mac3(+) cells and B220(+) B cells was less in demyelinated lesions of Fgfr2\(^{ind-/-}\) mice. Furthermore, expression of IL‐1β, TNF‐α and CD200 was less in Fgfr2\(^{ind-/-}\) mice than controls. Fgfr2ind−/− mice showed an upregulation of PLP and downregulation of the remyelination inhibitors SEMA3A and TGF‐β expression. These data suggest that cell‐specific deletion of FGFR2 in oligodendrocytes has anti‐inflammatory and neuroprotective effects accompanied by changes in FGF/FGFR dependent signalling, inflammatory cytokines and expression of remyelination inhibitors. Thus, FGFRs in oligodendrocytes may represent potential targets for the treatment of inflammatory and demyelinating diseases including MS.
Arrhythmogenic cardiomyopathy (ACM) is characterized by fibro-fatty replacement of the myocardium, heart failure and life-threatening ventricular arrhythmias. Causal mutations were identified in genes encoding for proteins of the desmosomes, predominantly plakophilin-2 (PKP2) and desmoglein-2 (DSG2). We generated gene-edited knock-out iPSC lines for PKP2 (JMUi001-A-2) and DSG2 (JMUi001-A-3) using the CRISPR/Cas9 system in a healthy control iPSC background (JMUi001A). Stem cell-like morphology, robust expression of pluripotency markers, embryoid body formation and normal karyotypes confirmed the generation of high quality iPSCs to provide a novel isogenic human in vitro model system mimicking ACM when differentiated into cardiomyocytes.
Contribution of adventitia-derived stem and progenitor cells to new vessel formation in tumors
(2021)
Blocking tumor vascularization has not yet come to fruition to the extent it was hoped for, as angiogenesis inhibitors have shown only partial success in the clinic. We hypothesized that under- appreciated vascular wall-resident stem and progenitor cells (VW-SPCs) might be involved in tumor vascularization and influence effectiveness of anti-angiogenic therapy. Indeed, in patient samples, we observed that vascular adventitia-resident CD34\(^+\) VW-SPCs are recruited to tumors in situ from co-opted vessels. To elucidate this in detail, we established an ex vivo model using concomitant embedding of multi-cellular tumor spheroids (MCTS) and mouse aortic rings (ARs) into collagen
gels, similar to the so-called aortic ring assay (ARA). Moreover, ARA was modified by removing the ARs’ adventitia that harbors VW-SPCs. Thus, this model enabled distinguishing the contribution of VW-SPCs from that of mature endothelial cells (ECs) to new vessel formation. Our results show that the formation of capillary-like sprouts is considerably delayed, and their number and network formation were significantly reduced by removing the adventitia. Substituting iPSC-derived neural spheroids for MCTS resulted in distinct sprouting patterns that were also strongly influenced by the
presence or absence of VW-SPCs, also underlying the involvement of these cells in non-pathological vascularization. Our data suggest that more comprehensive approaches are needed in order to block all of the mechanisms contributing to tumor vascularization.
Hereditary retinal degenerations like retinitis pigmentosa (RP) are among the leading causes of blindness in younger patients. To enable in vivo investigation of cellular and molecular mechanisms responsible for photoreceptor cell death and to allow testing of therapeutic strategies that could prevent retinal degeneration, animal models have been created. In this study, we deeply characterized the transcriptional profile of mice carrying the transgene rhodopsin V20G/P23H/P27L (VPP), which is a model for autosomal dominant RP. We examined the degree of photoreceptor degeneration and studied the impact of the VPP transgene-induced retinal degeneration on the transcriptome level of the retina using next generation RNA sequencing (RNASeq) analyses followed by weighted correlation network analysis (WGCNA). We furthermore identified cellular subpopulations responsible for some of the observed dysregulations using in situ hybridizations, immunofluorescence staining, and 3D reconstruction. Using RNASeq analysis, we identified 9256 dysregulated genes and six significantly associated gene modules in the subsequently performed WGCNA. Gene ontology enrichment showed, among others, dysregulation of genes involved in TGF-β regulated extracellular matrix organization, the (ocular) immune system/response, and cellular homeostasis. Moreover, heatmaps confirmed clustering of significantly dysregulated genes coding for components of the TGF-β, G-protein activated, and VEGF signaling pathway. 3D reconstructions of immunostained/in situ hybridized sections revealed retinal neurons and Müller cells as the major cellular population expressing representative components of these signaling pathways. The predominant effect of VPP-induced photoreceptor degeneration pointed towards induction of neuroinflammation and the upregulation of neuroprotective pathways like TGF-β, G-protein activated, and VEGF signaling. Thus, modulation of these processes and signaling pathways might represent new therapeutic options to delay the degeneration of photoreceptors in diseases like RP.
Der epithelialen Präsenz des Carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) in Prostatadrüsen wird eine tumorsupprimierende Funktion zugeschrieben. Maligne Veränderungen des Prostatadrüsenepithels bei einem PCa führen zu einer Abnahme der epithelialen CEACAM1-Expression, zu einem Verlust der Zellpolarität und zu einer erhöhten Zellproliferation (prostatische intraepitheliale Neoplasie (PIN)). Während des PIN-Stadiums exprimieren benachbarte Blut- und Lymphgefäße CEACAM1. CEACAM1 selbst wirkt pro-angiogen und stimuliert die Gefäßneubildung und auch die Neubildung von Lymphgefäßen, Lymphangiogenese. Seine Rolle in der Tumor-Lymphangiogenese und dadurch bedingten Metastasierung von Tumoren wurde bisher nicht ausreichend geklärt. Ziel dieser Arbeit war es, die Rolle von CEACAM1 bei der lymphogenen PCa-Metastasierung anhand von immunhistochemischen (IHC) Analysen am humanem PCa-Prostata- und Lymphknoten-(LN)-Gewebe, sowie im Mausmodell zu analysieren.
Laut den Immunfluoreszenzanalysen traten in den PIN-Arealen signifikant mehr CEACAM1-positive Blut- und Lymphgefäße auf, als in den darauffolgenden Tumorstadien. Weiter wurde eine CEACAM1-Expression in LN-Sinusgewebe bereits bei Niedrig-Risiko-Patienten (pN0) detektiert. Diese frühe CEACAM1-Expression trat auch in den LN im PCa-Mausmodell auf. Weiter wurde im LN-Gewebe von „Hoch-Risiko“-Patienten (pN1) eine luminale CEACAM1-Expression innerhalb der aus Tumorzellen bestehenden Drüsen beobachtet, die mit der CEACAM1-Expression in nativen Prostatadrüsen vergleichbar ist. Auch das angiogen-aktivierte Gefäßendothel von pN0- und pN1-LN war CEACAM1-positiv. Bei Hoch-Risiko-Patienten (pN1) nahmen die CEACAM1-positiven Blut- und Lymphgefäße im Tumorstroma mit zunehmender Dedifferenzierung des Gewebes ab. Die CEACAM1/PSA-Doppelimmun-fluoreszenzanalysen ergaben eine heterogene Expression der beiden Marker bei Intermediate-risk-Patienten und mit zunehmender Dedifferenzierung des Tumorgewebes einen epithelialen Verlust der CEACAM1-Expression in den PSA-positiven G3-Tumordrüsen. Das Fehlen von PSA in pN0-LN und die nachweisbare Expression von PSA in pN1-LN bestätigten PSA als geeigneten PCa-Zellmarker in LN. In pN1-LN ohne Drüsenbildung traten Zellansammlungen mit einer nach außen gerichteten CEACAM1-positiven Front und einem im Zentrum liegenden PSA-positiven Bereich auf. Diese Befunde belegen einen Zusammenhang zwischen der endothelialen CEACAM1-Expression im Sinus und der Mikrometastasierungswahrscheinlichkeit im pN0-LN-Gewebe von PCa-Patienten. Potentiell lässt sich daher im Niedrig-Risiko-PCa-Patientenkollektiv über eine CEACAM1-Bestimmung in LN das Risiko für eine Metastasierung frühzeitig erkennen.
Hintergrund - Die Multiple Sklerose (MS) ist bis heute eine nur teilweise verstandene Autoimmunerkrankung des zentralen Nervensystems (ZNS). Das Tiermodell der experimentellen autoimmunen Enzephalomyelitis (EAE) ermöglicht die Erforschung von Teilaspekten der Pathogenese der MS und kann zur Etablierung von Therapeutika herangezogen werden. Die MP4-abhängige EAE ermöglicht als Mausmodell die gezielte Erforschung der Rolle der B-Zelle als Akteur in der Pathogenese der MS. Diese Dissertation untersuchte den Effekt des S1P1-Rezeptor-Modulators FTY720 (Fingolimod) auf die Immunantwort der autoreaktiven B-Zellen in der Peripherie sowie im ZNS.
Methoden - MP4-immunisierte Mäuse erhielten 50 Tage nach dem EAE-Krankheitsbeginn oral appliziertes FTY720 über einen Zeitraum von 30 Tagen. Die Tiere wurden nach dem Auftreten der Krankheitssymptome täglich klinisch evaluiert. Die MP4-spezifische B-Zell-Immunantwort und die MP4-spezifische humorale Immunreaktion wurden mittels ELISPOT und ELISA ausgewertet. Die Verteilung der T- und B-Zell-Anteile im peripheren Blut der Mäuse sowie die Aufteilung der B-Zell-Subsets in der Milz wurden mittels Durchflusszytometrie quantifiziert. Mittels Immunhistochemie wurden die B- und T-Zell-Ansammlungen im ZNS der Mäuse hinsichtlich ihrer Entwicklung in tertiär lymphatische Organe (TLOs) untersucht.
Ergebnisse - In diesem Versuchsaufbau zeigte FTY720 keine signifikante Verbesserung des klinischen Krankheitsverlaufes der Tiere. Der Anteil von T-Zellen im peripheren Blut der Mäuse war unter der Therapie mit FTY720 signifikant reduziert, während die Anzahl an B-Zellen nicht-signifikant beeinflusst wurde. Bei der Untersuchung der B-Zell-Subtypen in der Milz fiel zunächst ein erhöhter Anteil an B220+-B-Zellen auf, während die Verteilung der weiteren Subsets nicht-signifikant verändert war. Unter der Therapie mit FTY720 zeigte sich keine Reduktion bereits etablierter B-Zell-Aggregate im ZNS, allerdings ist eine inhibierte Entwicklung in TLOs zu diskutieren.
Zusammenfassung - Diese Arbeit impliziert unterschiedliche Effekte von FTY720 auf die B-Zellen in einem B-Zell-abhängigen chronischen Mausmodell der MS.
Rubus admirabilis Drenckhahn ist eine tetraploide neue Brombeerart der Rubus-Sektion Rubus, Serie Vestiti. Die Stängelblätter sind 5-zählig, hand- bis schwach fußförmig geteilt mit länglich obovaten, zugespitzen Endblättchen und anliegend behaarter Oberseite und hellgrün schimmernder, fühlbar weich behaarter Unterseite. Die Schösslinge sind mäßig bogig (bis zu 2m), teilweise kletternd, stumpfwinklig, graugrün bis stumpfbraun, dicht behaart mit zahlreichen gestielten Drüsen und Borsten. Stachel: 7−15/5 cm, schlank, 4−6mm lang, gerade, überwiegend 30-45º geneigt. Die Blütenstiele sind dicht behaart (abstehend und teilweise anliegend), mit 2−4/cm schlanken, geraden bis leicht gekrümmten Stachelchen (1−2 mm lang) und zahlreichen gestielten Drüsen (0,3−0,5 mm lang) sowie einigen Borsten. Die Art ist schattentolerant und bevorzugt feuchte Böden. Der Typusfundort ist wahrscheinlich der Ansiedlungs- oder Ursprungsort der Art. Er liegt westlich der Stadt Garding auf der nordfriesischen Halbinsel Eiderstedt (mehrere hundert Sträucher und Gebüsche). Dort wurden im Zuge einer Aufforstung 1970 mehrere nichtheimische Brombeerarten eingeschleppt. Rubus admirabilis hat sich südlich bis Heide in Dithmarschen und nördlich bis Amrum ausgebreitet (maximaler Arealdurchmesser von 70 km) und befindet sich in einer expansiven Phase.
Da die Pathogenese der Multiplen Sklerose (MS) bis heute nicht vollständig geklärt ist, befassten wir uns mit der Rolle CEACAM1-exprimierender Immunzellen bei Patienten mit MS und untersuchten diese mittels durchflusszytometrischer Untersuchung. Bei CEACAM1 (Carcinoembryonic-antigen-related cell adhesion molecule) handelt es sich um ein Zelladhäsionsmolekül, das sowohl an inter- als auch intrazellulären Signalmechanismen modulatorisch beteiligt ist. Anhand unserer Ergebnisse scheint CEACAM1 keine zentrale Rolle in der Pathogenese der MS zu spielen. Es ließ sich jedoch eine signifikante Erhöhung CD56+dim NK-Zellen (natürliche Killerzellen) im peripheren Blut von Patienten mit schubförmig remittierender MS feststellen. Dies stützt die These, dass die „dim“-Subpopulation der NK-Zellen eine proinflammatorische Rolle in der Pathogenese der MS einnehmen könnte. Demnach sollte in Zukunft hinsichtlich der Entwicklung neuer Biomarker in der MS der Fokus auf NK-Zellen und Monozyten sowie deren Subpopulationen gerichtet werden.
Viele Organoide sind bisher nur stark vereinfachte Modelle der Originalgewebe, da sie nur aus dem Gewebsparenchym bestehen. Um neurale Organoide näher an das Originalgewebe zu bringen, ist ein wichtiger Schritt mesenchymale Anteile zu integrieren. In dieser Arbeit war die wichtige Fragenstellung, ob neurale Organoide sich mit mesodermalen Progenitorzellen zu einem gemeinsamen Gewebe vereinigen lassen.
Um die Generierung von neuro-mesenchymalen Organoiden zu erreichen, wurden geeignete Differenzierungsprotokolle zur Erzeugung neuroepithelialer und mesodermaler Aggregate aus humanen induzierten pluripotenten Stammzellen etabliert. Anschließend wurden die Sphäroide vereinigt und eingehend histologisch charakterisiert. Darüber hinaus wurde die Organoidentwicklung unter dem Einfluss von Hypoxie analysiert. Um die Organoide anschaulich mit der tatsächlichen Embryogenese vergleichen zu können, wurden Schnitte von Hühnerembryonen angefertigt. Die neuro-mesenchymalen Organoide wurden insgesamt 280 Tage kultiviert und an verschieden Zeitpunkten untersucht.
Die hier präsentierten Daten zeigen, dass die erzeugten neuro-mesenchymalen Organoide viele Aspekte der natürlichen Embryogenese in Zellkultur nachahmen können. So wurde die Ausbildung neuralrohrähnlicher Strukturen, die von einem perineuralen Gefäßplexus umgeben sind, gezeigt. Des Weiteren wurde eine Interaktion von Astrozyten/radiale Gliazellen mit dem entstehenden Gefäßnetz beobachtet. Schließlich zeigten sich das Einwandern von mikrogliaartigen Zellen aus dem mesenchymalen Organoidteil in das Nervengewebe.
Diese Arbeit bildet die Basis für die Generierung neuro-mesenchymaler Organoide als realistisches Modellsystem für die Entwicklung des Nervensystems. Solche Modellsysteme können für die Erforschung von Krankheiten, Toxizitätsstudien sowie Medikamententests verwendet werden.
Forum Geobotanicum ist eine elektronische Plattform, deren Zielsetzung darin besteht, neue Erkenntnisse der geobotanischen Forschung in der Europäischen Union mit Schwerpunkt Mitteleuropa umfassend zu verbreiten. Das Journal befasst sich mit allen Fragen von Verbreitung, Ökologie, Morphologie und Taxonomie von Gefäßpflanzen und soll das gesamte Spektrum der Geobotanik von molekularbiologischen Aspekten bis zu Umwelt- und Naturschutzfragen abdecken. Der Hauptfokus liegt auf der Publikation von Originaluntersuchungen und Übersichtsartikeln sowie Behandlung aktueller Fragen des Naturschutzes. Die Zielgruppen sind Personen mit Allgemeinkenntnissen in der Botanik und Floristik sowie Spezialisten auf den Gebieten der Geobotanik und Pflanzensystematik.
Das Journal soll keine Zeitschrift in Druckform ersetzen, sondern eine Ergänzung zu den traditionellen Publikationsorganen bilden. Der Vorteil der Zeitschrift liegt in ihrer Flexibilität und raschen Publikationszeit nach Begutachtung der eingereichten Manuskripte und den Möglichkeiten, in größerem Umfang Fotografien und andere Abbildungen zu veröffentlichen. Der Vorteil einer elektronischen Zeitschrift besteht weiterhin darin, dass die Veröffentlichungen weltweit jedermann sofort zugänglich sind. Viele durchaus wichtige Untersuchungen aus dem Bereich der Geobotanik erscheinen in lokalen Publikationsorganen, wie Jahrbüchern und Heimatkalendern, oder auch im Eigenverlag. Da solche Veröffentlichungen bibliographisch kaum erfasst werden, können sie auch nicht in adäquater Weise wahrgenommen werden. Forum Geobotanicum soll ermöglichen, dass auch solche Publikationen in einer Literaturrubrik bekannt gemacht werden und ggf. nach Klärung von Copyright-Fragen als Supplemente der Zeitschrift ins Netz gestellt werden. Forum Geobotanicum nutzt die Vorteile des Internets, indem es abrufbare Hilfen, wie ein Verzeichnis von Adressen, Pflanzenlisten etc. zur Verfügung stellt. Insgesamt soll die Kommunikation zwischen Geobotanikern in Mitteleuropa erleichtert und eine Kommunikationsplattform etabliert werden, die die Aktivitäten auf dem gesamten Wissenschaftsgebiet stimuliert.
Das Journal ist uneigennützig und für Autoren und Benutzer kostenfrei. Für die Kostendeckung sind Sponsoren erwünscht, denen eine begrenzte Möglichkeit zur Darstellung eingeräumt werden kann. In der Anfangsphase wird das Journal von einem kleinen Herausgebergremiumbetrieben. Sollte sich Forum Geobotanicum erfolgreich weiter entwickeln, ist an eine Erweiterung des Herausgebergremiums auf Experten aus allen Nationen des mitteleuropäischen Raums gedacht. Um eine langfristige Verfügbarkeit der Publikationen zu gewährleisten, wird jeder Jahrgang von Forum Geobotanicum ausgedruckt, gebunden und mit digitalem Datenträger versehen an ausgewählte Universitätsbibliotheken, Landes- und Staatsbibliotheken Deutschlands und wichtiger Städte Mitteleuropas zur Archivierung und Ausleihe versandt.
Bei Patienten, die an einer speziellen Form der MS erkrankten, konnten Entzündungsinfiltrate in den Meningen nachgewiesen werden, die in ihrem Aufbau lymphoidem Gewebe ähnelten. Das Auftreten dieser Infiltrate war mit einem schwereren Krankheitsverlauf assoziiert. Das Mausmodell der B-Zell-abhängigen MP4-induzierten experimentellen autoimmunen Enzephalomyelitis (EAE) zeigt in den Kleinhirnen der Mäuse Infiltrate, die den Infiltraten beim Menschen ähneln.
Wir nutzten die MP4-induzierte EAE, um die Mechanismen der Erkrankungsentstehung und Progression besser zu verstehen. Ziel dieser Arbeit war es intakte und stabile Ribonukleinsäuren (RNA) aus den Infiltraten der Mäuse zu isolieren. Sowie Identifizierung von Gene, die während verschiedener Stadien der zerebralen Entzündungsreaktion hochreguliert waren.
Wir verglichen die Möglichkeiten der RNA-Isolation bei Paraffin-eingebettetem Gewebe und kryofixiertem Gewebe. Um die Vergleichbarkeit der Qualitäts- und Quantitätsanalyse zu gewährleisten, wurde für jede Probe eine RNA Integritätsnummer (RIN) ermittelt.
Wir führten eine Laser Capture Microdissection (LCM) und anschließende Gensequenzierung der zerebralen Infiltrate bei Mäusen durch, bei denen eine MP4-abhängige EAE ausgelöst wurde. Des Weiteren verglichen wir die Ergebnisse mit den Expressionsprofilen von sekundär lymphatischen Organen (SLOs).
Insgesamt konnten wir 43 Gene herausfiltern, die im Vergleich zu den Kontrollgruppen hochreguliert waren.
Die Entwicklung von ektopen lymphatischen Strukturen (ELS) im zentralen Nervensystem (ZNS) ist ein komplexer und bisher wenig verstandener Prozess. In dieser Studie beobachteten wir 43 Gene, die während der Entwicklung von B- Zell-Infiltraten in den Kleinhirnen von MP4-immunisierten Mäusen signifikant hochreguliert waren. Von diesen Genen wurden bereits 14 im Zusammenhang mit der MS erwähnt und sind zum Teil Gegenstand aktiver Forschung.
Background
Traumatic separation of the pubic symphysis can destabilize the pelvis and require surgical fixation to reduce symphyseal gapping. The traditional approach involves open reduction and the implantation of a steel symphyseal plate (SP) on the pubic bone to hold the reposition. Despite its widespread use, SP-fixation is often associated with implant failure caused by screw loosening or breakage.
Methods
To address the need for a more reliable surgical intervention, we developed and tested two titanium cable-clamp implants. The cable served as tensioning device while the clamp secured the cable to the bone. The first implant design included a steel cable anterior to the pubic symphysis to simplify its placement outside the pelvis, and the second design included a cable encircling the pubic symphysis to stabilize the anterior pelvic ring. Using highly reproducible synthetic bone models and a limited number of cadaver specimens, we performed a comprehensive biomechanical study of implant stability and evaluated surgical feasibility.
Results
We were able to demonstrate that the cable-clamp implants provide stability equivalent to that of a traditional SP-fixation but without the same risks of implant failure. We also provide detailed ex vivo evaluations of the safety and feasibility of a trans-obturator surgical approach required for those kind of fixation.
Conclusion
We propose that the developed cable-clamp fixation devices may be of clinical value in treating pubic symphysis separation.
Pathological angiogenesis promotes tumor growth, metastasis, and atherosclerotic plaque rupture. Macrophages are key players in these processes. However, whether these macrophages differentiate from bone marrow-derived monocytes or from local vascular wall-resident stem and progenitor cells (VW-SCs) is an unresolved issue of angiogenesis. To answer this question, we analyzed vascular sprouting and alterations in aortic cell populations in mouse aortic ring assays (ARA). ARA culture leads to the generation of large numbers of macrophages, especially within the aortic adventitia. Using immunohistochemical fate-mapping and genetic in vivo-labeling approaches we show that 60% of these macrophages differentiate from bone marrow-independent Ly6c\(^{+}\)/Sca-1\(^{+}\) adventitial progenitor cells. Analysis of the NCX\(^{−/-}\) mouse model that genetically lacks embryonic circulation and yolk sac perfusion indicates that at least some of those progenitor cells arise yolk sac-independent. Macrophages represent the main source of VEGF in ARA that vice versa promotes the generation of additional macrophages thereby creating a pro-angiogenetic feedforward loop. Additionally, macrophage-derived VEGF activates CD34\(^{+}\) progenitor cells within the adventitial vasculogenic zone to differentiate into CD31\(^{+}\) endothelial cells. Consequently, depletion of macrophages and VEGFR2 antagonism drastically reduce vascular sprouting activity in ARA. In summary, we show that angiogenic activation induces differentiation of macrophages from bone marrow-derived as well as from bone marrow-independent VW-SCs. The latter ones are at least partially yolk sac-independent, too. Those VW-SC-derived macrophages critically contribute to angiogenesis, making them an attractive target to interfere with pathological angiogenesis in cancer and atherosclerosis as well as with regenerative angiogenesis in ischemic cardiovascular disorders.
Transforming growth factor β (TGFβ) signaling has manifold functions such as regulation of cell growth, differentiation, migration, and apoptosis. Moreover, there is increasing evidence that it also acts in a neuroprotective manner. We recently showed that TGFβ receptor type 2 (Tgfbr2) is upregulated in retinal neurons and Müller cells during retinal degeneration. In this study we investigated if this upregulation of TGFβ signaling would have functional consequences in protecting retinal neurons. To this end, we analyzed the impact of TGFβ signaling on photoreceptor viability using mice with cell type-specific deletion of Tgfbr2 in retinal neurons and Müller cells (Tgfbr2\(_{ΔOC}\)) in combination with a genetic model of photoreceptor degeneration (VPP). We examined retinal morphology and the degree of photoreceptor degeneration, as well as alterations of the retinal transcriptome. In summary, retinal morphology was not altered due to TGFβ signaling deficiency. In contrast, VPP-induced photoreceptor degeneration was drastically exacerbated in double mutant mice (Tgfbr2\(_{ΔOC}\); VPP) by induction of pro-apoptotic genes and dysregulation of the MAP kinase pathway. Therefore, TGFβ signaling in retinal neurons and Müller cells exhibits a neuroprotective effect and might pose promising therapeutic options to attenuate photoreceptor degeneration in humans.
Transcriptional and distributional profiling of microglia in retinal angiomatous proliferation
(2022)
Macular neovascularization type 3, formerly known as retinal angiomatous proliferation (RAP), is a hallmark of age-related macular degeneration and is associated with an accumulation of myeloid cells, such as microglia (MG) and infiltrating blood-derived macrophages (MAC). However, the contribution of MG and MAC to the myeloid cell pool at RAP sites and their exact functions remain unknown. In this study, we combined a microglia-specific reporter mouse line with a mouse model for RAP to identify the contribution of MG and MAC to myeloid cell accumulation at RAP and determined the transcriptional profile of MG using RNA sequencing. We found that MG are the most abundant myeloid cell population around RAP, whereas MAC are rarely, if ever, associated with late stages of RAP. RNA sequencing of RAP-associated MG showed that differentially expressed genes mainly contribute to immune-associated processes, including chemotaxis and migration in early RAP and proliferative capacity in late RAP, which was confirmed by immunohistochemistry. Interestingly, MG upregulated only a few angiomodulatory factors, suggesting a rather low angiogenic potential. In summary, we showed that MG are the dominant myeloid cell population at RAP sites. Moreover, MG significantly altered their transcriptional profile during RAP formation, activating immune-associated processes and exhibiting enhanced proliferation, however, without showing substantial upregulation of angiomodulatory factors.
Ongoing research to fight cancer, one of the dominant diseases of the 21st century has led to big progress especially when it comes to understanding the tumor growth and metastasis. This includes the discovery of the molecular mechanisms of tumor vascularization, which is critically required for establishment of tumor metastasis.
Formation of new blood vessels is the first step in tumor vascularization. Therefore, understanding the molecular and cellular basis of tumor vascularization attracted a significant effort studying in biomedical research. The blood vessels for supplying tumor can be formed by sprouting from pre-existing vessels, a process called angiogenesis, or by vasculogenesis, that is de novo formation of blood vessels from not fully differentiated progenitor cell populations. Vasculogenic endothelial progenitor cells (EPCs) can either be activated from populations in the bone marrow reaching the pathological region via the circulation or they can be recruited from local reservoirs. Neovessel formation influences tumor progression, hence therapeutic response model systems of angiogenesis/vasculogenesis are necessary to study the underlying mechanisms. Although, initially the research in this area focused more on angiogenesis, it is now well understood that both angiogenesis and postnatal vasculogenesis contribute to neovessel formation in adult under both most pathological as well as physiological conditions. Studies in the last two decades demonstrate that in addition to the intimal layer of fully differentiated mature endothelial cells (ECs) and various smaller supplying vessels (vasa vasorum) that can serve as a source for new vessels by angiogenesis, especially the adventitia of large and medium size blood vessels harbors various vascular wall-resident stem and progenitor cells (VW-SPCs) populations that serve as a source for new vessels by postnatal vasculogenesis. However, little is known about the potential role of VW-SPCs in tumor vascularization.
To this end, the present work started first to establish a modified aortic ring assay (ARA) using mouse aorta in order to study the contribution of vascular adventitia-resident VW-SPCs to neovascularization in general and in presence of tumor cells. ARA is already established an ex vivo model for neovascularization allows to study the morphogenetic events of complex new vessel formation that includes all layers of mature blood vessels, a significant advantage over the assays that employ monolayer endothelial cell cultures. Moreover, in contrast to assays employing endothelial cells monocultures, both angiogenic and vasculogenic events take place during new vessel formation in ARA although the exact contribution of these two processes to new vessel formation cannot be easily distinguished in conventional ARA. Thus, in this study, a modified protocol for the ARA (mdARA) was established by either removing or keeping the aortic adventitia in place. The mdARA allows to distinguish the role of VW-SPCs from those of other aortic layers. The present data show that angiogenic sprouting from mature aortic endothelium was markedly delayed when the adventitial layer was removed. Furthermore, the network between the capillary-like sprouts was significantly reduced in absence of aortic adventitia. Moreover, the stabilization of new sprouts by assembling the NG2+ pericyte-like cells that enwrapped the endothelial sprouts from the outside was improved when the adventitial layer remained in place.
Next, mimicking the tumor-vessel adventitia-interaction, multicellular tumor spheroids (MCTS) and aortic rings (ARs) with or without adventitia of C57BL/6-Tg (UBC-GFP) mice were confronted within the collagen gel and cultured ex vivo. This 3D model enabled analysis of the mobilization, migration and capillary-like sprouts formation by VW-SPCs within tumor-vessel wall-interface in comparison to tumor-free side of the ARs. Interestingly, while MCTS preferred the uptake of single vascular adventitia-derived cells, neural spheroids were directly penetrated by capillary-like structures that were sprouted from the aortic adventitia. In summary, the model established in this work allows to study new vessel formation by both postnatal vasculogenesis and angiogenesis under same conditions. It can be applied in various mouse models including reporter mouse models, e.g. Cxcr1 CreER+/mTmG+/- mice, in which GFP-marked macrophages of the vessel wall were directly observed as they mobilized from their niche and migrated into collagen gel. Another benefit of the model is that it can be used for testing different factors such as small molecules, growth factors, cytokines, and drugs with both pro- and anti-angiogenic/vasculogenic effects.
Extracellular vesicle (EV)-mediated intercellular communication through exosomes, microvesicles (MVs) and apoptotic bodies has been shown to be implicated in various physiological as well as pathological processes such as the development and progression of atherosclerosis. While the cellular machinery controlling EV formation and composition has been studied extensively, little is known about the underlying morphological processes. This study focuses on a detailed ultrastructural analysis of the different steps of EV formation and release in Myocardial Endothelial (MyEnd) and Aortic Endothelial (AoEnd) cells cultured under serum starvation and inflammatory stimulation with TNF-α. Detailed morphological analyses were conducted applying and comparing different high- resolution light and electron microscopic methods. In this study, we could depict all steps of MV biogenesis named in literature. However, during the study of exosome biogenesis, we discovered a yet undescribed process: Instead of a direct fusion with the plasma membrane, multivesicular bodies were incorporated into a new distinct cellular compartment bound by fenestrated endothelium first. This may present a novel step in exosome biogenesis and warrants further study. Regarding the conditions of cell cultivation, we observed that the commonly used serum starvation causes MyEnd cells, but not AoEnd cells, to enter apoptosis after 48 hours. When preparing functional EV studies, we therefore recommend assessing the morphological condition of the serum-starved cells at different cultivation points first. When evaluating MV production, a statistical analysis showed that the more time AoEnd cells spent in cultivation under serum starvation, the higher the percentage of MV producing cells. However, additional TNF-α stimulation induced a significantly higher MV production than serum starvation alone. Lastly, our results show that TNF-α stimulation of AoEnd cells in vitro leads to the upregulation of CD44, an adhesion molecule critical in the early stages of atherosclerosis. CD44 was then depicted on the surface of generated MVs and exosomes. We conclude that under inflammatory conditions, EVs can mediate the transfer of CD44 from endothelial cells to target cells. This could be a novel mechanism by which MVs contribute to the development and progression of atherosclerotic disease and should be clarified by further studies.
Reversible protein phosphorylation is a posttranslational modification of regulatory proteins involved in cardiac signaling pathways. Here, we focus on the role of protein phosphatase 2A (PP2A) for cardiac gene expression and stress response using a transgenic mouse model with cardiac myocyte-specific overexpression of the catalytic subunit of PP2A (PP2A-TG). Gene and protein expression were assessed under basal conditions by gene chip analysis and Western blotting. Some cardiac genes related to the cell metabolism and to protein phosphorylation such as kinases and phosphatases were altered in PP2A-TG compared to wild type mice (WT). As cardiac stressors, a lipopolysaccharide (LPS)-induced sepsis in vivo and a global cardiac ischemia in vitro (stop-flow isolated perfused heart model) were examined. Whereas the basal cardiac function was reduced in PP2A-TG as studied by echocardiography or as studied in the isolated work-performing heart, the acute LPS- or ischemia-induced cardiac dysfunction deteriorated less in PP2A-TG compared to WT. From the data, we conclude that increased PP2A activity may influence the acute stress tolerance of cardiac myocytes.
Mycobacterium tuberculosis (Mtb) inhibits host oxidative stress responses facilitating its survival in macrophages; however, the underlying molecular mechanisms are poorly understood. Here, we identified a Mtb acetyltransferase (Rv3034c) as a novel counter actor of macrophage oxidative stress responses by inducing peroxisome formation. An inducible Rv3034c deletion mutant of Mtb failed to induce peroxisome biogenesis, expression of the peroxisomal β-oxidation pathway intermediates (ACOX1, ACAA1, MFP2) in macrophages, resulting in reduced intracellular survival compared to the parental strain. This reduced virulence phenotype was rescued by repletion of Rv3034c. Peroxisome induction depended on the interaction between Rv3034c and the macrophage mannose receptor (MR). Interaction between Rv3034c and MR induced expression of the peroxisomal biogenesis proteins PEX5p, PEX13p, PEX14p, PEX11β, PEX19p, the peroxisomal membrane lipid transporter ABCD3, and catalase. Expression of PEX14p and ABCD3 was also enhanced in lungs from Mtb aerosol-infected mice. This is the first report that peroxisome-mediated control of ROS balance is essential for innate immune responses to Mtb but can be counteracted by the mycobacterial acetyltransferase Rv3034c. Thus, peroxisomes represent interesting targets for host-directed therapeutics to tuberculosis.
A growing body of scientific evidence indicates that protein homeostasis, also designated as proteostasis, is causatively linked to chronic diabetic nephropathy (DN). Experimental studies have demonstrated that the insulin signaling in podocytes maintain the homeostatic unfolded protein response (UPR). Insulin signaling via the insulin receptor non-canonically activates the spliced X-box binding protein-1 (sXBP1), a highly conserved endoplasmic reticulum (ER) transcription factor, which regulates the expression of genes that control proteostasis. Defective insulin signaling in mouse models of diabetes or the genetic disruption of the insulin signaling pathway in podocytes propagates hyperglycemia induced maladaptive UPR and DN. Insulin resistance in podocytes specifically promotes activating transcription factor 6 (ATF6) dependent pathogenic UPR. Akin to insulin, recent studies have identified that the cytoprotective effect of anticoagulant serine protease-activated protein C (aPC) in DN is mediated by sXBP1. In mouse models of DN, treatment with chemical chaperones that improve protein folding provides an additional benefit on top of currently used ACE inhibitors. Understanding the molecular mechanisms that transmute renal cell specific adaptive responses and that deteriorate renal function in diabetes will enable researchers to develop new therapeutic regimens for DN. Within this review, we focus on the current understanding of homeostatic mechanisms by which UPR is regulated in DN.
Takotsubo syndrome (TTS), also known as the transient left ventricular apical ballooning syndrome, is in contemporary times known as novel acute cardiac syndrome. It is characterized by transient left ventricular apical akinesis and hyperkinesis of the basal left ventricular portions. Although the precise etiology of TTS is unknown, events like the sudden release of stress hormones, such as the catecholamines and the increased inflammatory status might be plausible causes leading to the cardiovascular pathologies. Recent studies have highlighted that an imbalance in lipid accumulation might promote a deviant immune response as observed in TTS. However, there is no information on comprehensive profiling of serum lipids of TTS patients. Therefore, we investigated a detailed quantitative lipid analysis of TTS patients using ES-MSI. Our results showed significant differences in the majority of lipid species composition in the TTS patients compared to the control group. Furthermore, the computational analyses presented was able to link the altered lipids to the pro-inflammatory cytokines and disseminate possible mechanistic pathways involving TNFα and IL-6. Taken together, our study provides an extensive quantitative lipidome of TTS patients, which may provide a valuable Pre-diagnostic tool. This would facilitate the elucidation of the underlying mechanisms of the disease and to prevent the development of TTS in the future.
Adenocarcinoma lung cancer is a type of non-small cell lung carcinoma (NSCLC), which accounts for 85% of lung cancer incidence globally. The therapies that are being applied, both conventional therapies and antibody-based treatments, are still found to have side effects. Several previous studies have demonstrated the ability of the ethanolic extract of Ocimum sanctum Linn. (EEOS) as an ethnomedicine with anti-tumor properties. The aim of this study was to determine the effect of Ocimum sanctum Linn. ethanolic extract in inhibiting the proliferation, angiogenesis, and migration of A549 cells (NSCLC). The adhesion as well as the migration assay was performed. Furthermore, enzyme-linked immunosorbent assay (ELISA) was used to measure the expression of αvβ3 integrins, α5β1 integrins, and VEGF. The cells were divided into the following treatment groups: control (non-treated/NT), positive control (AP3/inhibitor β3 80 µg/mL), cisplatin (9 µg/mL), and EEOS at concentrations of 50, 70, 100, and 200 µg/mL. The results showed that EEOS inhibits the adhesion ability and migration of A549 cells, with an optimal concentration of 200 µg/mL. ELISA testing showed that the group of A549 cells given EEOS 200 µg/mL presented a decrease in the optimal expression of integrin α5β1, integrin αvβ3, and VEGF.
Diabetes mellitus is a common disease affecting more than 537 million adults worldwide. The microvascular complications that occur during the course of the disease are widespread and affect a variety of organ systems in the body. Diabetic retinopathy is one of the most common long-term complications, which include, amongst others, endothelial dysfunction, and thus, alterations in the blood-retinal barrier (BRB). This particularly restrictive physiological barrier is important for maintaining the neuroretina as a privileged site in the body by controlling the inflow and outflow of fluid, nutrients, metabolic end products, ions, and proteins. In addition, people with diabetic retinopathy (DR) have been shown to be at increased risk for systemic vascular complications, including subclinical and clinical stroke, coronary heart disease, heart failure, and nephropathy. DR is, therefore, considered an independent predictor of heart failure. In the present review, the effects of diabetes on the retina, heart, and kidneys are described. In addition, a putative common microRNA signature in diabetic retinopathy, nephropathy, and heart failure is discussed, which may be used in the future as a biomarker to better monitor disease progression. Finally, the use of miRNA, targeted neurotrophin delivery, and nanoparticles as novel therapeutic strategies is highlighted.
Blood vessel organoids are an important in vitro model to understand the underlying mechanisms of human blood vessel development and for toxicity testing or high throughput drug screening. Here we present a novel, cost-effective, and easy to manufacture vascular organoid model. To engineer the organoids, a defined number of human induced pluripotent stem cells are seeded in non-adhesive agarose coated wells of a 96-well plate and directed towards a lateral plate mesoderm fate by activation of Wnt and BMP4 signaling. We observe the formation of a circular layer of angioblasts around days 5–6. Induced by VEGF application, CD31\(^+\) vascular endothelial cells appear within this vasculogenic zone at approximately day 7 of organoid culture. These cells arrange to form a primitive vascular plexus from which angiogenic sprouting is observed after 10 days of culture. The differentiation outcome is highly reproducible, and the size of organoids is scalable depending on the number of starting cells. We observe that the initial vascular ring forms at the interface between two cell populations. The inner cellular compartment can be distinguished from the outer by the expression of GATA6, a marker of lateral plate mesoderm. Finally, 14-days-old organoids were transplanted on the chorioallantois membrane of chicken embryos resulting in a functional connection of the human vascular network to the chicken circulation. Perfusion of the vessels leads to vessel wall maturation and remodeling as indicated by the formation of a continuous layer of smooth muscle actin expressing cells enwrapping the endothelium. In summary, our organoid model recapitulates human vasculogenesis, angiogenesis as well as vessel wall maturation and therefore represents an easy and cost-effective tool to study all steps of blood vessel development and maturation directly in the human setting without animal experimentation.
Protocadherins (PCDHs) belong to the cadherin superfamily and represent the largest subgroup of calcium-dependent adhesion molecules. In the genome, most PCDHs are arranged in three clusters, α, β, and γ on chromosome 5q31. PCDHs are highly expressed in the central nervous system (CNS). Several PCDHs have tumor suppressor functions, but their individual role in primary brain tumors has not yet been elucidated. Here, we examined the mRNA expression of PCDHGC3, a member of the PCDHγ cluster, in non-cancerous brain tissue and in gliomas of different World Health Organization (WHO) grades and correlated it with the clinical data of the patients. We generated a PCDHGC3 knockout U343 cell line and examined its growth rate and migration in a wound healing assay. We showed that PCDHGC3 mRNA and protein were significantly overexpressed in glioma tissue compared to a non-cancerous brain specimen. This could be confirmed in glioma cell lines. High PCDHGC3 mRNA expression correlated with longer progression-free survival (PFS) in glioma patients. PCDHGC3 knockout in U343 resulted in a slower growth rate but a significantly faster migration rate in the wound healing assay and decreased the expression of several genes involved in WNT signaling. PCDHGC3 expression should therefore be further investigated as a PFS-marker in gliomas. However, more studies are needed to elucidate the molecular mechanisms underlying the PCDHGC3 effects.
Recombinant beta interferons-1 (IFNβ-1) are used as first line therapies in patients with relapsing multiple sclerosis (MS), a chronic inflammatory and neurodegenerative disease of the CNS. IFNβ-1a/b has moderate effects on the prevention of relapses and slowing of disease progression. Fibroblast growth factors (FGFs) and FGF receptors (FGFRs) are known to play a key role in the pathology of MS and its model EAE. To investigate the effects of short-term treatment with s.c. IFNβ-1a versus the combined application of s.c. IFNβ-1a and oligodendrocyte-specific deletion of FGFR1 (Fgfr1\(^{ind−/−}\) mice) in MOG\(_{35-55}\)-induced EAE. IFNβ-1a (30 mg/kg) was applied s.c. from days 0–7 p.i. of EAE in controls and Fgfr1\(^{ind−/−}\) mice. FGFR signaling proteins associated with inflammation/degeneration in MS/EAE were analyzed by western blot in the spinal cord. Further, FGFR1 in Oli-neu oligodendrocytes were inhibited by PD166866 and treated with IFNβ-1a (400 ng/mL). Application of IFNβ-1a over 8 days resulted in less symptoms only at the peak of disease (days 9–11) compared to controls. Application of IFNβ-1a in Fgfr1\(^{ind−/−}\) mice resulted in less symptoms primarily in the chronic phase of EAE. Fgfr1\(^{ind−/−}\) mice treated with IFNβ-1a showed increased expression of pERK and BDNF. In Oli-neu oligodendrocytes, treatment with PD166866 and IFNβ-1a also showed an increased expression of pERK and BDNF/TrkB. These data suggest that the beneficial effects in the chronic phase of EAE and on signaling molecules associated with ERK and BDNF expression are caused by the modulation of FGFR1 and not by interferon beta-1a. FGFR may be a potential target for therapy in MS.
Early treatment with glucocorticoids could help reduce both cytotoxic and vasogenic edema, leading to improved clinical outcome after stroke. In our previous study, isosteviol sodium (STVNA) demonstrated neuroprotective effects in an in vitro stroke model, which utilizes oxygen-glucose deprivation (OGD). Herein, we tested the hypothesis that STVNA can activate glucocorticoid receptor (GR) transcriptional activity in brain microvascular endothelial cells (BMECs) as previously published for T cells. STVNA exhibited no effects on transcriptional activation of the glucocorticoid receptor, contrary to previous reports in Jurkat cells. However, similar to dexamethasone, STVNA inhibited inflammatory marker IL-6 as well as granulocyte-macrophage colony-stimulating factor (GM-CSF) secretion. Based on these results, STVNA proves to be beneficial as a possible prevention and treatment modality for brain ischemia-reperfusion injury-induced blood–brain barrier (BBB) dysfunction.
Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) ist ein multifunktionales Zell-Zell Adhäsionsprotein, das in eine Vielzahl an zellulären Prozessen involviert ist, wie zum Beispiel der Differenzierung von Geweben, der Tumorsuppression, Metastasierung, Angiogenese und Apoptose. Außerdem hat es modulierende Eigenschaften auf die angeborene und erworbene Immunantwort. In der vorliegenden Arbeit charakterisierte ich initial die Lokalisation und die CEACAM1-exprimierenden Zelltypen im Auge und bestimmte quantitativ die Expression von Ceacam1 in der Retina und Choroidea zu unterschiedlichen Zeitpunkten.
Es zeigte sich hierbei, dass Ceacam1 zu allen untersuchten Zeitpunkten, sowohl während der Entwicklung als auch im adulten retinalen und choroidalen Gewebe nachweisbar war. Mittels Immunhistochemie konnte die Expression von CEACAM1 im Corneaepithel, den Gefäßen der Iris und des Ziliarkörpers, im nicht-pigmentierten Epithel des Ziliarkörpers, sowie in den retinalen und choroidalen Gefäßen nachgewiesen werden. Durch Doppelfärbung mit Kollagen IV konnte die endotheliale Expression von CEACAM1 in den Endothelzellen der Gefäße bestätigt werden.
Im zweiten Teil meiner Arbeit untersuchte ich die Funktion von CEACAM1 im Auge und verglich dazu wildtypische Retinae mit Cc1-/--Retinae. Es zeigten sich keine offensichtlichen morphologischen Veränderungen der retinalen Schichten und die anschließend durchgeführten morphometrischen Analysen der Schichtdicken der retinalen Neurone zeigte keine Anzeichen einer Neurodegeneration. Allerdings waren in Cc1-/--Retinae kleine Zysten und IBA1 positive, phagozytisch aktive Zellen im subneuroretinalen Raum, also dem Bereich zwischen RPE und den Außensegmenten der Photorezeptoren zu erkennen. Die anschließend durchgeführten Expressionsanalysen immunmodulierender Faktoren und von Mitgliedern des TGF-β-Signalwegs in retinalen und choroidealen Proben wildtypischer und Cc1-/--Mäusen zeigten keine veränderte Expression für Iba1, Ccl2 sowie Tnf-α. Jedoch konnten signifikant erhöhte Werte für TGF-β1 in der Gruppe der 2-4 als auch der Gruppe der 9 Monate alten Cc1-/--Retinae im Vergleich zu wildtypischen Retinae nachgewiesen werden. Basierend auf den Daten der vorliegenden Arbeit kann geschlussfolgert werden, dass die Deletion von CEACAM1 unter physiologischen Bedingungen die Struktur der Retina und Choroidea nicht offensichtlich beeinflusst. Allerdings führt die Deletion zu erhöhten Tgfβ1 Spiegeln in der Retina und zur Aktivierung und Akkumulation von IBA1 positiven Zellen im subneuroretinalen Raum.